US20090181875A1 - Subtilase variants - Google Patents
Subtilase variants Download PDFInfo
- Publication number
- US20090181875A1 US20090181875A1 US12/403,859 US40385909A US2009181875A1 US 20090181875 A1 US20090181875 A1 US 20090181875A1 US 40385909 A US40385909 A US 40385909A US 2009181875 A1 US2009181875 A1 US 2009181875A1
- Authority
- US
- United States
- Prior art keywords
- g97ga
- l96lg
- variant
- g97gv
- subtilase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101710135785 Subtilisin-like protease Proteins 0.000 title claims abstract description 106
- 239000003599 detergent Substances 0.000 claims abstract description 80
- 239000000203 mixture Substances 0.000 claims abstract description 43
- 238000004140 cleaning Methods 0.000 claims abstract description 11
- 102200118280 rs33918343 Human genes 0.000 claims description 256
- 102220499813 Carbonic anhydrase 2_N62D_mutation Human genes 0.000 claims description 195
- 102220049910 rs587783527 Human genes 0.000 claims description 66
- 102220083974 rs863224729 Human genes 0.000 claims description 47
- 102220105272 rs879254401 Human genes 0.000 claims description 47
- 102000035195 Peptidases Human genes 0.000 claims description 36
- 108091005804 Peptidases Proteins 0.000 claims description 36
- 239000004365 Protease Substances 0.000 claims description 34
- 102220036452 rs137882485 Human genes 0.000 claims description 34
- 238000012986 modification Methods 0.000 claims description 27
- 230000004048 modification Effects 0.000 claims description 27
- 108010020132 microbial serine proteinases Proteins 0.000 claims description 24
- 102220099575 rs878853725 Human genes 0.000 claims description 21
- 238000006467 substitution reaction Methods 0.000 claims description 21
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
- -1 glycoamylase Proteins 0.000 claims description 18
- 102220495809 Alkaline ceramidase 3_S99A_mutation Human genes 0.000 claims description 17
- 102220486919 Nucleosome-remodeling factor subunit BPTF_V28I_mutation Human genes 0.000 claims description 17
- 102220528606 Ribonuclease P/MRP protein subunit POP5_S99D_mutation Human genes 0.000 claims description 17
- 102220358598 c.296C>G Human genes 0.000 claims description 17
- 102220286163 rs781670952 Human genes 0.000 claims description 17
- 102220485938 Probable ATP-dependent RNA helicase DHX34_K94R_mutation Human genes 0.000 claims description 12
- 102200108308 rs1555526631 Human genes 0.000 claims description 12
- 102220276603 rs863224701 Human genes 0.000 claims description 12
- 108090001060 Lipase Proteins 0.000 claims description 11
- 102000004882 Lipase Human genes 0.000 claims description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 11
- 239000013604 expression vector Substances 0.000 claims description 11
- 102220317648 rs1553902415 Human genes 0.000 claims description 11
- 102220638186 Alkaline phosphatase, germ cell type_A98R_mutation Human genes 0.000 claims description 10
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 10
- 239000004367 Lipase Substances 0.000 claims description 10
- 102220350531 c.80A>G Human genes 0.000 claims description 10
- 235000019421 lipase Nutrition 0.000 claims description 10
- 102220215697 rs200971068 Human genes 0.000 claims description 10
- 102220044621 rs587781437 Human genes 0.000 claims description 10
- 102220041795 rs587780747 Human genes 0.000 claims description 9
- 102000013142 Amylases Human genes 0.000 claims description 8
- 108010065511 Amylases Proteins 0.000 claims description 8
- 102220533262 Glycophorin-B_T22S_mutation Human genes 0.000 claims description 8
- 235000019418 amylase Nutrition 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 7
- 102220317884 rs1553902417 Human genes 0.000 claims description 7
- 102220066015 rs794726955 Human genes 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 102220061994 rs144792613 Human genes 0.000 claims description 6
- 102220167663 rs535525554 Human genes 0.000 claims description 6
- 102220475366 Iduronate 2-sulfatase_S87N_mutation Human genes 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 230000028327 secretion Effects 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 102220527020 Cytochrome b5 reductase 4_S99V_mutation Human genes 0.000 claims description 3
- 102220578554 Mediator of RNA polymerase II transcription subunit 8_P14H_mutation Human genes 0.000 claims description 3
- 102220613710 Semaphorin-3D_G97N_mutation Human genes 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 102200074805 rs2234919 Human genes 0.000 claims description 3
- 102220082985 rs375349172 Human genes 0.000 claims description 3
- 102220248108 rs377129682 Human genes 0.000 claims description 3
- 102220082984 rs863224701 Human genes 0.000 claims description 3
- 102200037603 rs878854026 Human genes 0.000 claims description 3
- 239000004382 Amylase Substances 0.000 claims description 2
- 108010059820 Polygalacturonase Proteins 0.000 claims description 2
- 108010005400 cutinase Proteins 0.000 claims description 2
- 102200034374 rs6092 Human genes 0.000 claims 150
- 102200025035 rs786203989 Human genes 0.000 claims 3
- 102100026189 Beta-galactosidase Human genes 0.000 claims 2
- 102220481680 Rap guanine nucleotide exchange factor 3_A16P_mutation Human genes 0.000 claims 2
- 108010005774 beta-Galactosidase Proteins 0.000 claims 2
- 108090000371 Esterases Proteins 0.000 claims 1
- 108010059881 Lactase Proteins 0.000 claims 1
- 102220627127 Polycystin-1_S99I_mutation Human genes 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 229940059442 hemicellulase Drugs 0.000 claims 1
- 108010002430 hemicellulase Proteins 0.000 claims 1
- 229940116108 lactase Drugs 0.000 claims 1
- 108010062085 ligninase Proteins 0.000 claims 1
- 102200023384 rs587777213 Human genes 0.000 claims 1
- 102220312163 rs772475317 Human genes 0.000 claims 1
- 230000004075 alteration Effects 0.000 abstract description 10
- 230000001747 exhibiting effect Effects 0.000 abstract description 4
- 230000003197 catalytic effect Effects 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 102220243326 rs1183892581 Human genes 0.000 description 484
- 102000004190 Enzymes Human genes 0.000 description 89
- 108090000790 Enzymes Proteins 0.000 description 89
- 229940088598 enzyme Drugs 0.000 description 86
- 108090000623 proteins and genes Proteins 0.000 description 39
- 210000004027 cell Anatomy 0.000 description 30
- 102000004169 proteins and genes Human genes 0.000 description 24
- 238000000034 method Methods 0.000 description 22
- 239000004753 textile Substances 0.000 description 22
- 102220536696 Hemoglobin subunit epsilon_V30I_mutation Human genes 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 20
- 229910052717 sulfur Inorganic materials 0.000 description 20
- 229910052720 vanadium Inorganic materials 0.000 description 20
- 102220523847 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13_A16P_mutation Human genes 0.000 description 19
- 102000005158 Subtilisins Human genes 0.000 description 19
- 108010056079 Subtilisins Proteins 0.000 description 19
- 235000019419 proteases Nutrition 0.000 description 18
- 102220307898 rs142045411 Human genes 0.000 description 18
- 229910052799 carbon Inorganic materials 0.000 description 17
- 102220316977 rs1553638767 Human genes 0.000 description 17
- 101000922061 Homo sapiens Beta-catenin-like protein 1 Proteins 0.000 description 16
- 102220228196 rs1064793029 Human genes 0.000 description 16
- 102220104422 rs879253976 Human genes 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 108090000787 Subtilisin Proteins 0.000 description 15
- 239000012085 test solution Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 230000035772 mutation Effects 0.000 description 13
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 102220228121 rs1064795729 Human genes 0.000 description 13
- 102220554731 Hepatocyte nuclear factor 1-alpha_G20R_mutation Human genes 0.000 description 12
- 238000003556 assay Methods 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- 238000011056 performance test Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 235000014469 Bacillus subtilis Nutrition 0.000 description 11
- 108010084185 Cellulases Proteins 0.000 description 11
- 102000005575 Cellulases Human genes 0.000 description 11
- 238000012217 deletion Methods 0.000 description 11
- 230000037430 deletion Effects 0.000 description 11
- 102200094595 rs34422225 Human genes 0.000 description 11
- 102220261561 rs374050750 Human genes 0.000 description 11
- 238000003780 insertion Methods 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 102220274985 rs1007915253 Human genes 0.000 description 10
- 102220126814 rs886044376 Human genes 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 102220581852 Caspase recruitment domain-containing protein 16_S57P_mutation Human genes 0.000 description 9
- 102220493017 Cystatin-M_F50S_mutation Human genes 0.000 description 9
- 102000012479 Serine Proteases Human genes 0.000 description 9
- 108010022999 Serine Proteases Proteins 0.000 description 9
- 239000000654 additive Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 102000040430 polynucleotide Human genes 0.000 description 9
- 108091033319 polynucleotide Proteins 0.000 description 9
- 239000002157 polynucleotide Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 102220283107 rs1218848193 Human genes 0.000 description 9
- 102200067146 rs80357017 Human genes 0.000 description 9
- 102200024254 rs864309502 Human genes 0.000 description 9
- 102220566483 GDNF family receptor alpha-1_V68L_mutation Human genes 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 230000000996 additive effect Effects 0.000 description 8
- 102220363249 c.40C>A Human genes 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 102220283756 rs1300016035 Human genes 0.000 description 8
- 102220276615 rs763693540 Human genes 0.000 description 8
- 230000003248 secreting effect Effects 0.000 description 8
- 229910052721 tungsten Inorganic materials 0.000 description 8
- 102220642476 Disintegrin and metalloproteinase domain-containing protein 7_P14S_mutation Human genes 0.000 description 7
- 102220596013 Uncharacterized protein C6orf15_V81A_mutation Human genes 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 102220175371 rs149447253 Human genes 0.000 description 7
- 102220041350 rs200343185 Human genes 0.000 description 7
- 102200082931 rs33945546 Human genes 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 102000003992 Peroxidases Human genes 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 229940025131 amylases Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 102220223348 rs1060499949 Human genes 0.000 description 6
- 102200047002 rs61752065 Human genes 0.000 description 6
- 102220264454 rs762630679 Human genes 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 241000193422 Bacillus lentus Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 108700020962 Peroxidase Proteins 0.000 description 5
- 102220500183 Putative tubulin-like protein alpha-4B_L75I_mutation Human genes 0.000 description 5
- 102220596054 Uncharacterized protein C6orf15_N43D_mutation Human genes 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 102220348394 c.266A>G Human genes 0.000 description 5
- 102220370155 c.67G>A Human genes 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 102220202129 rs1057521108 Human genes 0.000 description 5
- 102220226174 rs1064793939 Human genes 0.000 description 5
- 102220250458 rs140403872 Human genes 0.000 description 5
- 102220267892 rs1555193020 Human genes 0.000 description 5
- 102200032605 rs34349826 Human genes 0.000 description 5
- 102220064465 rs748902766 Human genes 0.000 description 5
- 102220254284 rs755928199 Human genes 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- VBAOEVKQBLGWTH-UHFFFAOYSA-N 2-pyridin-4-ylethanethiol Chemical compound SCCC1=CC=NC=C1 VBAOEVKQBLGWTH-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 102220584207 Cellular tumor antigen p53_A88T_mutation Human genes 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000004453 electron probe microanalysis Methods 0.000 description 4
- UFZOPKFMKMAWLU-UHFFFAOYSA-N ethoxy(methyl)phosphinic acid Chemical compound CCOP(C)(O)=O UFZOPKFMKMAWLU-UHFFFAOYSA-N 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 102220224495 rs1060503668 Human genes 0.000 description 4
- 102200145454 rs121908575 Human genes 0.000 description 4
- 102220392418 rs192256606 Human genes 0.000 description 4
- 102220285860 rs368993118 Human genes 0.000 description 4
- 102220213113 rs587780088 Human genes 0.000 description 4
- 102200093149 rs77938727 Human genes 0.000 description 4
- 238000002741 site-directed mutagenesis Methods 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 108091005658 Basic proteases Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 3
- 229910021536 Zeolite Inorganic materials 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 3
- 239000003752 hydrotrope Substances 0.000 description 3
- 108010003855 mesentericopeptidase Proteins 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 210000001322 periplasm Anatomy 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000010457 zeolite Substances 0.000 description 3
- MHKLKWCYGIBEQF-UHFFFAOYSA-N 4-(1,3-benzothiazol-2-ylsulfanyl)morpholine Chemical compound C1COCCN1SC1=NC2=CC=CC=C2S1 MHKLKWCYGIBEQF-UHFFFAOYSA-N 0.000 description 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 102220587343 Cellular tumor antigen p53_S99P_mutation Human genes 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 102000016559 DNA Primase Human genes 0.000 description 2
- 108010092681 DNA Primase Proteins 0.000 description 2
- 108010083608 Durazym Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241001522878 Escherichia coli B Species 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000223218 Fusarium Species 0.000 description 2
- 241000223198 Humicola Species 0.000 description 2
- 241001480714 Humicola insolens Species 0.000 description 2
- 102100027612 Kallikrein-11 Human genes 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- 102220624011 Non-histone chromosomal protein HMG-14_R19S_mutation Human genes 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 102220490204 Replication factor C subunit 4_S99I_mutation Human genes 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101000611441 Solanum lycopersicum Pathogenesis-related leaf protein 6 Proteins 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 241000223258 Thermomyces lanuginosus Species 0.000 description 2
- 101710152431 Trypsin-like protease Proteins 0.000 description 2
- 108010082503 alkaline elastase YaB Proteins 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000002979 fabric softener Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 229920000847 nonoxynol Polymers 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102200115358 rs121918322 Human genes 0.000 description 2
- 102200090662 rs137852491 Human genes 0.000 description 2
- 102220274086 rs1379627026 Human genes 0.000 description 2
- 102220082775 rs144148008 Human genes 0.000 description 2
- 102200093472 rs1800574 Human genes 0.000 description 2
- 102220341170 rs199565868 Human genes 0.000 description 2
- 102220170946 rs567155861 Human genes 0.000 description 2
- 102200024065 rs72657696 Human genes 0.000 description 2
- 102220052333 rs727503494 Human genes 0.000 description 2
- 102220276580 rs752209909 Human genes 0.000 description 2
- 102220121884 rs768260007 Human genes 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000003828 vacuum filtration Methods 0.000 description 2
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 1
- IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 1
- 241000193375 Bacillus alcalophilus Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 1
- 101000642797 Bacillus amyloliquefaciens Subtilisin BPN' Proteins 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 101000642771 Bacillus licheniformis Subtilisin Carlsberg Proteins 0.000 description 1
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000149420 Bothrometopus brevis Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- 244000251987 Coprinus macrorhizus Species 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100038946 Proprotein convertase subtilisin/kexin type 6 Human genes 0.000 description 1
- 241000168225 Pseudomonas alcaligenes Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589630 Pseudomonas pseudoalcaligenes Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 241000577556 Pseudomonas wisconsinensis Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 241001468239 Streptomyces murinus Species 0.000 description 1
- 108700037663 Subtilisin-like proteases Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 101000835043 Thermoactinomyces vulgaris Thermitase Proteins 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241001313536 Thermothelomyces thermophila Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960005051 fluostigmine Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical class CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical class OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920000196 poly(lauryl methacrylate) Polymers 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 102200131574 rs11556620 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 108010075550 termamyl Proteins 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
Definitions
- the present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: wash performance, thermal stability, storage stability or catalytic activity.
- the variants of the invention are suitable for use in, e.g., cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions.
- the present invention also relates to isolated DNA sequences encoding the variants, expression vectors, host cells, and methods for producing and using the variants of the invention. Further, the present invention relates to cleaning and detergent compositions comprising the variants of the invention.
- Enzymes used in such formulations comprise proteases, lipases, amylases, cellulases, as well as other enzymes, or mixtures thereof. Commercially the most important enzymes are proteases.
- proteases protein engineered variants of naturally occurring wild type proteases, e.g., Durazym®, Relase®, Alcalase®, Savinase®, Primase®, Duralase®, Esperase®, Ovozyme® and Kannase® (Novozymes A/S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, FN3TM and FN4TM (Genencor International, Inc.). Further, a number of protease variants are described in the art. A thorough list of prior art protease variants is given in WO 99/27082.
- an object of the present invention is to provide improved subtilase variants for such purposes.
- the present invention relates to a subtilase variant comprising at least
- modification(s) comprise(s): deletion, insertion and/or substitution of an amino acid residue selected from the group consisting of K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S and T.
- the present invention relates to a subtilase variant comprising
- the present invention relates to a subtilase variant comprising at least one of the alterations disclosed in Table I below:
- each position corresponds to a position of the amino acid sequence of subtilisin BPN′, shown in FIG. 1 and SEQ ID NO: 1.
- the present invention relates to an isolated polynucleotide encoding a subtilase variant of the invention.
- the present invention relates to an expression vector comprising the isolated polynucleotide of the invention.
- the present invention relates to a microbial host cell transformed with the expression vector of the invention.
- the present invention relates to a method for producing a subtilase variant according to the invention, wherein a host according to the invention is cultured under conditions conducive to the expression and secretion of the variant, and the variant is recovered.
- the present invention relates to a cleaning or detergent composition, preferably a laundry or dish wash composition, comprising the variant of the invention.
- the present invention relates to a subtilase variant comprising at least one of the alterations disclosed in Table II below:
- subtilase variants of the inventions having one or more of the alterations: G97GA + H120D + P131H + Q137E L111I + Q137E G97GV + Q137H G97GA + Q137H + N218S T22TQ + S101P L96LG + H120N + P131S + Q137H G97GV + H120D + Q137H L96LG + H120N + P131S + Q137H V4A + G97GV + H120D G97GA + H120N + Q137E L111V + Q137E + G211D L111I + H120N + Q137E L21LW + G100S + V139L + Q245V L96LG + P131T + Q137H V68A + Q137D L96LG + H120N + P131S L96LG + H120Q + Q137E G97GA + H120Y + Q137H K94N + H120N + P131H G97GA + Q137D G97GV + H120Q L96LG + P131P131
- each position corresponds to a position of the amino acid sequence of subtilisin BPN′, shown in FIG. 1 and SEQ ID NO: 1.
- the present invention relates to a subtilase variant comprising one of the alterations N252D and N252M.
- the present invention relates to a subtilase variant comprising one or more of the alterations M119L, I, V, A, S; M175L, I, V, A, S and M222L, I, V, A, S in combination with the subtilase variants listed in tables I and II above.
- FIG. 1 shows an alignment between subtilisin BPN′ (a) (BASBPN) and subtilisin 309 (b) (BLSAVI). This alignment is in this patent application used as a reference for numbering the residues.
- subtilase enzyme variants produced or contemplated according to the invention, the following nomenclatures and conventions have been adapted for ease of reference:
- a frame of reference is first defined by aligning the isolated or parent enzyme with subtilisin BPN′ (BASBPN).
- Another method is to use known recognized alignments between subtilases, such as the alignment indicated in WO 91/00345. In most cases the differences will not be of any importance.
- subtilisin 309 SEQ ID NO.2
- subtilisin 309 SEQ ID NO.2
- FIG. 1 subtilisin 309
- FIG. 1 indicated by asterixes (*).
- Enzymes cleaving the amide linkages in protein substrates are classified as proteases, or (interchangeably) peptidases (see Walsh, 1979 , Enzymatic Reaction Mechanisms . W.H. Freeman and Company, San Francisco, Chapter 3).
- subtilase BPN′ (BASBPN) sequence.
- BPN′ sequence see FIG. 1 , SEQ ID NO: 1 or Siezen et al., 1991 , Protein Engng. 4: 719-737.
- a serine protease is an enzyme which catalyzes the hydrolysis of peptide bonds, and in which there is an essential serine residue at the active site (White, Handler and Smith, 1973 “Principles of Biochemistry,” Fifth Edition, McGraw-Hill Book Company, NY, pp. 271-272).
- the bacterial serine proteases have molecular weights in the 20,000 to 45,000 Dalton range. They are inhibited by diisopropylfluorophosphate. They hydrolyze simple terminal esters and are similar in activity to eukaryotic chymotrypsin, also a serine protease.
- subtilases A sub-group of the serine proteases tentatively designated subtilases has been proposed by Siezen et al., 1991 , Protein Engng. 4: 719-737 and Siezen et al., 1997 , Protein Science 6: 501-523. They are defined by homology analysis of more than 170 amino acid sequences of serine proteases previously referred to as subtilisin-like proteases. A subtilisin was previously often defined as a serine protease produced by Gram-positive bacteria or fungi, and according to Siezen et al. now is a subgroup of the subtilases. A wide variety of subtilases have been identified, and the amino acid sequence of a number of subtilases has been determined. For a more detailed description of such subtilases and their amino acid sequences reference is made to Siezen et al. (1997).
- subtilisin 168 subtilisin 168
- subtilisin BPN′ subtilisin BPN′
- subtilisin Carlsberg ALCALASE®, NOVOZYMES A/S
- subtilisin DY subtilisin DY
- subtilases I-S2 or high alkaline subtilisins
- Sub-group I-S2 proteases are described as highly alkaline subtilisins and comprises enzymes such as subtilisin PB92 (BAALKP) (MAXACAL®, Genencor International Inc.), subtilisin 309 (SAVINASE®, NOVOZYMES A/S), subtilisin 147 (BLS147) (ESPERASE®, NOVOZYMES A/S), and alkaline elastase YaB (BSEYAB).
- SAVINASE® is marketed by NOVOZYMES A/S. It is subtilisin 309 from B. lentus and differs from BAALKP only in one position (N87S). SAVINASE® has the amino acid sequence designated b) in FIG. 1 and in SEQ ID NO: 2.
- parent subtilase describes a subtilase defined according to Siezen et al. (1991 and 1997). For further details see description of “Subtilases” above.
- a parent subtilase may also be a subtilase isolated from a natural source, wherein subsequent modifications have been made while retaining the characteristic of a subtilase.
- a parent subtilase may be a subtilase which has been prepared by the DNA shuffling technique, such as described by J. E. Ness et al., 1999 , Nature Biotechnology 17: 893-896.
- subtilase may be termed “wild type subtilase”.
- Organism Bacteria Gram-positive enzyme acronym Bacillus subtilis 168 subtilisin I168, apr BSS168 Bacillus amyloliquefaciens subtilisin BPN′ (NOVO) BASBPN Bacillus subtilis DY subtilisin DY BSSDY Bacillus licheniformis subtilisin Carlsberg BLSCAR Bacillus lentus subtilisin 309 BLSAVI Bacillus lentus subtilisin 147 BLS147 Bacillus alcalophilus PB92 subtilisin PB92 BAPB92 Bacillus YaB alkaline elastase YaB BYSYAB Thermoactinomyces vulgaris thermitase TVTHER
- modification(s) used herein is defined to include chemical modification of a subtilase as well as genetic manipulation of the DNA encoding a subtilase.
- the modification(s) can be replacement(s) of the amino acid side chain(s), substitution(s), deletion(s) and/or insertions in or at the amino acid(s) of interest.
- subtilase variant or mutated subtilase means a subtilase that has been produced by an organism which is expressing a mutant gene derived from a parent microorganism which possessed an original or parent gene and which produced a corresponding parent enzyme, the parent gene having been mutated in order to produce the mutant gene from which said mutated subtilase protease is produced when expressed in a suitable host.
- the GAP routine of the GCG package version 9.1 can be applied (infra) using the same settings.
- the output from the routine is besides the amino acid alignment the calculation of the “Percent Identity” between the two sequences.
- isolated when applied to a polynucleotide, denotes that the polynucleotide has been removed from its natural genetic milieu and is thus free of other extraneous or unwanted coding sequences, and is in a form suitable for use within genetically engineered protein production systems.
- isolated molecules are those that are separated from their natural environment and include cDNA and genomic clones.
- Isolated DNA molecules of the present invention are free of other genes with which they are ordinarily associated, but may include naturally occurring 5′ and 3′ untranslated regions such as promoters and terminators. The identification of associated regions will be evident to one of ordinary skill in the art (see for example, Dynan and Tijan, 1985 , Nature 316: 774-78).
- the term “an isolated polynucleotide” may alternatively be termed “a cloned polynucleotide”.
- the term “isolated” indicates that the protein has been removed from its native environment.
- the isolated protein is substantially free of other proteins, particularly other homologous proteins (i.e., “homologous impurities” (see below)).
- An isolated protein is more than 10% pure, preferably more than 20% pure, more preferably more than 30% pure, as determined by SDS-PAGE. Further it is preferred to provide the protein in a highly purified form, i.e., more than 40% pure, more than 60% pure, more than 80% pure, more preferably more than 95% pure, and most preferably more than 99% pure, as determined by SDS-PAGE.
- isolated protein may alternatively be termed “purified protein”.
- homologous impurities means any impurity (e.g., another polypeptide than the subtilase of the invention), which originate from the homologous cell where the subtilase of the invention is originally obtained from.
- the term “obtained from” as used herein in connection with a specific microbial source means that the polynucleotide and/or subtilase produced by the specific source, or by a cell in which a gene from the source has been inserted.
- substrate used in connection with a substrate for a protease should be interpreted in its broadest form as comprising a compound containing at least one peptide (amide) bond susceptible to hydrolysis by a subtilisin protease.
- product used in connection with a product derived from a protease enzymatic reaction should, in the context of the present invention, be interpreted to include the products of a hydrolysis reaction involving a subtilase protease.
- a product may be the substrate in a subsequent hydrolysis reaction.
- wash performance is used as an enzyme's ability to remove proteinaceous or organic stains present on the object to be cleaned during, e.g., wash or hard surface cleaning. See also the wash performance test in Example 3 herein.
- FIG. 1 shows an alignment between subtilisin BPN′ (a) and Savinase® (b) using the GAP routine mentioned above.
- the present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: wash performance, thermal stability, storage stability or catalytic activity.
- variants which are contemplated as being part of the invention are such variants where, when compared to the wild-type subtilase, one or more amino acid residues has been substituted, deleted or inserted, said variants comprising at least a) an insertion, substitution or deletion of one of the amino acid residues K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S,T in one or more of the positions 62, 68, 97, 98, 99, 106, 131, 170, 245, 252,
- modification(s) comprise(s): deletion, insertion and/or substitution of an amino acid residue selected from the group consisting of K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S and T.
- variants of the present invention comprises at least one or more of the alterations indicated in Table I and II, wherein
- each position corresponds to a position of the amino acid sequence of subtilisin
- BPN′ (SEQ ID NO: 1).
- a subtilase variant of the first aspect of the invention may be a parent or wild-type subtilase identified and isolated from nature. Such a parent wild-type subtilase may be specifically screened for by standard techniques known in the art.
- One preferred way of doing this may be by specifically PCR amplifying conserved DNA regions of interest from subtilases from numerous different microorganism, preferably different Bacillus strains.
- Subtilases are a group of conserved enzymes, in the sense that their DNA and amino acid sequences are homologous. Accordingly it is possible to construct relatively specific primers flanking the polynucleotide sequences of interest.
- PCR primers to amplify DNA from a number of different microorganisms, preferably different Bacillus strains, followed by DNA sequencing of said amplified PCR fragments, it will be possible to identify strains which produce subtilase variants of the invention.
- subtilase variant of the invention is predominantly a variant of a parent subtilase.
- a subtilase variant suitable for the uses described herein may be constructed by standard techniques known in the art such as by site-directed/random mutagenesis or by DNA shuffling of different subtilase sequences. See the “Material and Methods” section and Example 1 herein (vide infra) for further details.
- variants described herein may comprise one or more further modifications, in particular one or more further substitutions or insertions.
- the variants described herein may encompass mutation at more than just one position.
- the variant according to the invention may contain mutations at one position, two positions, three positions or more than three positions, such as four to eight positions.
- the parent subtilase belongs to the subgroups I-S1 or I-S2, especially subgroup I-S2, both for enzymes from nature or from the artificial creation of diversity, and for designing and producing variants from a parent subtilase.
- subtilase from the group consisting of BSS168 (BSSAS, BSAPRJ, BSAPRN, BMSAMP), BASBPN, BSSDY, BLSCAR (BLKERA, BLSCA1, BLSCA2, BLSCA3), BSSPRC, and BSSPRD, or functional variants thereof having retained the characteristic of sub-group I-S1.
- subtilase from the group consisting of BSAPRQ, BLS147 (BSAPRM, BAH101), BLSAVI (BSKSMK, BAALKP, BLSUBL), BYSYAB, BAPB92, TVTHER, and BSAPRS, or functional variants thereof having retained the characteristic of sub-group I-S2.
- subtilase is BLSAVI (Savinase®, NOVOZYMES A/S), and a preferred subtilase variant of the invention is accordingly a variant of Savinase®.
- the present invention also encompasses any of the above mentioned subtilase variants in combination with any other modification to the amino acid sequence thereof. Especially combinations with other modifications known in the art to provide improved properties to the enzyme are envisaged.
- the art describes a number of subtilase variants with different improved properties and a number of those are mentioned in the “Background of the invention” section herein (vide supra). Those references are disclosed here as references to identify a subtilase variant, which advantageously can be combined with a subtilase variant described herein.
- Such combinations comprise the positions: 222 (improves oxidation stability), 218 (improves thermal stability), substitutions in the Ca 2+ -binding sites stabilizing the enzyme, e.g., position 76, and many other apparent from the prior art.
- subtilase variant described herein may advantageously be combined with one or more modification(s) in any of the positions:
- a particular interesting variant is a variant, which, in addition to modifications according to the invention, contains the following substitutions:
- subtilase variants of the main aspect(s) of the invention are preferably combined with one or more modification(s) in any of the positions 129, 131 and 194, preferably as 129K, 131H and 194P modifications, and most preferably as P129K, P131H and A194P modifications. Any of those modification(s) are expected to provide a higher expression level of the subtilase variant in the production thereof.
- the wash performance of a selected variant of the invention may be tested in the wash performance test disclosed in Example 3 herein.
- the wash performance test may be employed to assess the ability of a variant, when incorporated in a standard or commercial detergent composition, to remove proteinaceous stains from a standard textile as compared to a reference system, namely the parent subtilase or a similar subtilase exhibiting an even better wash performance (incorporated in the same detergent system and tested under identical conditions).
- the enzyme variants of the present application were tested using the Automatic Mechanical Stress Assay (AMSA). With the AMSA test the wash performance of a large quantity of small volume enzyme-detergent solutions can be examined rapidly. Using this test, the wash performance of a selected variant can be initially investigated, the rationale being that if a selected variant does not show a significant improvement in the test compared to the parent subtilase, it is normally not necessary to carry out further test experiments.
- AMSA Automatic Mechanical Stress Assay
- variants which are particularly interesting for the purposes described herein are such variants which, when tested in a commercial detergent composition such as a US type detergent, an Asian type, a European type or a Latin American type detergent as described in the wash performance test (Example 3), shows an improved wash performance as compared to the parent subtilase tested under identical conditions.
- a commercial detergent composition such as a US type detergent, an Asian type, a European type or a Latin American type detergent as described in the wash performance test (Example 3)
- the improvement in the wash performance may be quantified by calculating the so-called intensity value (Int) defined in Example 3, herein.
- the variant of the invention when tested in the wash performance test has a Performance Score (S) of at least 1, preferably a Performance Score of 2, where:
- the variant of the invention fulfils the above criteria on at least the stated lowest level, more preferably at the stated highest level.
- subtilase genes Many methods for cloning a subtilase and for introducing substitutions, deletions or insertions into genes (e.g., subtilase genes) are well known in the art.
- subtilase variant of the invention In general standard procedures for cloning of genes and introducing mutations (random and/or site directed) into said genes may be used in order to obtain a subtilase variant of the invention.
- suitable techniques reference is made to Example 1 herein (vide infra) and (Sambrook et al., 1989, Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, N.Y.; Ausubel, F. M. et al. (eds.) “Current protocols in Molecular Biology”. John Wiley and Sons, 1995; Harwood, C. R., and Cutting, S. M. (eds.) “Molecular Biological Methods for Bacillus ”. John Wiley and Sons, 1990), and WO 96/34946.
- subtilase variant may be constructed by standard techniques for artificial creation of diversity, such as by DNA shuffling of different subtilase genes (WO 95/22625; Stemmer, 1994 , Nature 370: 389-91). DNA shuffling of, e.g., the gene encoding Savinase® with one or more partial subtilase sequences identified in nature, will after subsequent screening for improved wash performance variants, provide subtilase variants suitable for the purposes described herein.
- a recombinant expression vector comprising a DNA construct encoding the enzyme of the invention may be any vector that may conveniently be subjected to recombinant DNA procedures.
- the vector may be an autonomously replicating vector, i.e., a vector that exists as an extra-chromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid.
- the vector may be one that on introduction into a host cell is integrated into the host cell genome in part or in its entirety and replicated together with the chromosome(s) into which it has been integrated.
- the vector is preferably an expression vector in which the DNA sequence encoding the enzyme of the invention is operably linked to additional segments required for transcription of the DNA.
- the expression vector is derived from plasmid or viral DNA, or may contain elements of both.
- operably linked indicates that the segments are arranged so that they function in concert for their intended purposes, e.g., transcription initiates in a promoter and proceeds through the DNA sequence coding for the enzyme.
- the promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
- suitable promoters for use in bacterial host cells include the promoter of the Bacillus stearothermophilus maltogenic amylase gene, the Bacillus licheniformis alpha-amylase gene, the Bacillus amyloliquefaciens alpha-amylase gene, the Bacillus subtilis alkaline protease gene, or the Bacillus pumilus xylosidase gene, or the phage Lambda P R or P L promoters or the E. coli lac, trp or tac promoters.
- the DNA sequence encoding the enzyme of the invention may also, if necessary, be operably connected to a suitable terminator.
- the recombinant vector of the invention may further comprise a DNA sequence enabling the vector to replicate in the host cell in question.
- the vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the host cell, or a gene encoding resistance to, e.g., antibiotics like kanamycin, chloramphenicol, erythromycin, tetracycline, spectinomycine, or the like, or resistance to heavy metals or herbicides.
- a secretory signal sequence (also known as a leader sequence, prepro sequence or pre sequence) may be provided in the recombinant vector.
- the secretory signal sequence is joined to the DNA sequence encoding the enzyme in the correct reading frame.
- Secretory signal sequences are commonly positioned 5′ to the DNA sequence encoding the enzyme.
- the secretory signal sequence may be that normally associated with the enzyme or may be from a gene encoding another secreted protein.
- the DNA sequence encoding the present enzyme introduced into the host cell may be either homologous or heterologous to the host in question. If homologous to the host cell, i.e., produced by the host cell in nature, it will typically be operably connected to another promoter sequence or, if applicable, another secretory signal sequence and/or terminator sequence than in its natural environment.
- the term “homologous” is intended to include a DNA sequence encoding an enzyme native to the host organism in question.
- heterologous is intended to include a DNA sequence not expressed by the host cell in nature. Thus, the DNA sequence may be from another organism, or it may be a synthetic sequence.
- the host cell into which the DNA construct or the recombinant vector of the invention is introduced may be any cell that is capable of producing the present enzyme and includes bacteria, yeast, fungi and higher eukaryotic cells including plants.
- Examples of bacterial host cells which, on cultivation, are capable of producing the enzyme of the invention are gram-positive bacteria such as strains of Bacillus , such as strains of B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. coagulans, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. stearothermophilus, B. subtilis , or B. thuringiensis , or strains of Streptomyces , such as S. lividans or S. murinus , or gram-negative bacteria such as Escherichia coli.
- Bacillus such as strains of B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. coagulans, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. stearothermophilus, B
- the transformation of the bacteria may be effected by protoplast transformation, electroporation, conjugation, or by using competent cells in a manner known per se (cf. Sambrook et al., supra).
- the enzyme When expressing the enzyme in bacteria such as E. coli , the enzyme may be retained in the cytoplasm, typically as insoluble granules (known as inclusion bodies), or may be directed to the periplasmic space by a bacterial secretion sequence. In the former case, the cells are lysed and the granules are recovered and denatured after which the enzyme is refolded by diluting the denaturing agent. In the latter case, the enzyme may be recovered from the periplasmic space by disrupting the cells, e.g., by sonication or osmotic shock, to release the contents of the periplasmic space and recovering the enzyme.
- the enzyme When expressing the enzyme in gram-positive bacteria such as Bacillus or Streptomyces strains, the enzyme may be retained in the cytoplasm, or may be directed to the extracellular medium by a bacterial secretion sequence. In the latter case, the enzyme may be recovered from the medium as described below.
- the present invention provides a method of producing an isolated enzyme according to the invention, wherein a suitable host cell, which has been transformed with a DNA sequence encoding the enzyme, is cultured under conditions permitting the production of the enzyme, and the resulting enzyme is recovered from the culture.
- the medium used to culture the transformed host cells may be any conventional medium suitable for growing the host cells in question.
- the expressed subtilase may conveniently be secreted into the culture medium and may be recovered there-from by well-known procedures including separating the cells from the medium by centrifugation or filtration, precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
- the enzyme of the invention may be added to and thus become a component of a detergent composition.
- cleaning and detergent compositions are well described in the art and reference is made to WO 96/34946; WO 97/07202; WO 95/30011 for further description of suitable cleaning and detergent compositions.
- the detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
- the invention provides a detergent additive comprising the enzyme of the invention.
- the detergent additive as well as the detergent composition may comprise one or more other enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
- enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidas
- the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
- proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
- the protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease.
- alkaline proteases are subtilisins, especially those derived from Bacillus , e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279).
- trypsin-like proteases are trypsin (e.g., of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
- Examples of useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
- Preferred commercially available protease enzymes include Durazym®, Relase®, Alcalase®, Savinase®, Primase®, Duralase®, Esperase®, Ovozyme® and Kannase® (Novozymes A/S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OXPTM, FN2TM, FN3TM and FN4TM (Genencor International, Inc.).
- Suitable lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces ), e.g., from H. lanuginosa ( T. lanuginosus ) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase , e.g., from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1,372,034), P.
- lipase variants such as those described in WO 92/05249, WO 94/01541, EP 407 225, EP 260 105, WO 95/35381, WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
- Lipex® Lipex®
- Lipolase® Lipolase Ultra®
- Amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus , e.g., a special strain of B. licheniformis , described in more detail in GB 1,296,839.
- Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391, 408, and 444.
- amylases are Duramyl®, Termamyl®, Fungamyl® and BAN® (Novozymes A/S), RapidaseTM and PurastarTM (from Genencor International Inc.).
- Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Acremonium, Bacillus, Humicola, Fusarium, Pseudomonas, Thielavia , e.g., the fungal cellulases produced from Fusarium oxysporum, Humicola insolens , and Myceliophthora thermophila disclosed in U.S. Pat. Nos. 4,435,307, 5,648,263, 5,691,178, and 5,776,757 and WO 89/09259.
- cellulases are the alkaline or neutral cellulases having colour care benefits.
- Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940.
- Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, U.S. Pat. No. 5,457,046, U.S. Pat. No. 5,686,593, U.S. Pat. No. 5,763,254, WO 95/24471, WO 98/12307 and PCT/DK98/00299.
- cellulases include Celluzyme®, and Carezyme® (Novozymes A/S), ClazinaseTM, and Puradax HATTM (Genencor International Inc.), and KAC-500(B)TM (Kao Corporation).
- Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus , e.g., from C. cinereus , and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include Guardzyme® (Novozymes A/S).
- the detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
- a detergent additive of the invention i.e., a separate additive or a combined additive, can be formulated, e.g., as a granulate, a liquid, a slurry, etc.
- Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
- Non-dusting granulates may be produced, e.g., as disclosed in U.S. Pat. Nos. 4,106,991 and 4,661,452 and may optionally be coated by methods known in the art.
- waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
- Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
- Protected enzymes may be prepared according to the method disclosed in EP 238,216.
- the detergent composition of the invention may be in any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid.
- a liquid detergent may be aqueous, typically containing up to 70% water and 0-30% organic solvent, or non-aqueous.
- the detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic.
- the surfactants are typically present at a level of from 0.1% to 60% by weight.
- the detergent When included therein the detergent will usually contain from about 1% to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
- an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
- the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanol-amide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
- a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanol-amide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
- glucamides N-acyl N-alkyl derivatives of glucosamine
- the detergent may contain 0-65% of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylene-diaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenyl-succinic acid, soluble silicates or layered silicates (e.g., SKS-6 from Hoechst).
- a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylene-diaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenyl-succinic acid, soluble silicates or layered silicates (e.g., SKS-6 from Hoechst).
- the detergent may comprise one or more polymers.
- examples are carboxymethyl-cellulose, poly(vinylpyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinyl-pyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as poly-acrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
- the detergent may contain a bleaching system which may comprise a H 2 O 2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate.
- a bleaching system may comprise peroxyacids of, e.g., the amide, imide, or sulfone type.
- the detergent may also contain other conventional detergent ingredients such as, e.g., fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
- fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
- Detergent Examples 1 and 2 provide ranges for the composition of a typical Latin American detergent and a typical European powder detergent respectively.
- Group Subname Content Surfactants 0-30% Sulphonates 0-30% Sulphates 0-5% Soaps 0-5% Non-ionics 0-5% Cationics 0-5% FAGA 0-5% Bleach 0-20% SPT/SPM 0-15% NOBS, TAED 0-5% Builders 0-60% Phosphates 0-30% Zeolite 0-5% Na 2 OSiO 2 0-10% Na 2 CO 3 0-20% Fillers 0-40% Na 2 SO 4 0-40% Others up to 100% Polymers Enzymes Foam regulators Water Hydrotropes Others
- Group Subname Content Surfactants 0-30% Sulphonates 0-20% Sulphates 0-15% Soaps 0-10% Non-ionics 0-10% Cationics 0-10% Other 0-10% Bleach 0-30% SPT/SPM 0-30% NOBS + TAED 0-10% Builders 0-60% Phosphates 0-40% Zeolite 0-40% Na2OSiO2 0-20% Na2CO3 0-20% Fillers 0-40% Na2SO4 0-40% NaCl 0-40% Others up to 100% Polymers Enzymes Foam regulators Water Hydrotropes Others
- the enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in, e.g., WO 92/19709 and WO 92/19708.
- a polyol such as propylene glycol or glycerol
- a sugar or sugar alcohol lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid
- any single enzyme in particular the enzyme of the invention, may be added in an amount corresponding to 0.01-200 mg of enzyme protein per liter of wash liquor, preferably 0.05-50 mg of enzyme protein per liter of wash liquor, in particular 0.1-10 mg of enzyme protein per liter of wash liquor.
- the enzyme of the invention may additionally be incorporated in the detergent formulations disclosed in WO 97/07202 which is hereby incorporated as reference.
- Standard textile pieces are obtained from EMPA St. Gallen, Lerchfeldstrasse 5, CH-9014 St. Gallen, Switzerland. Especially type EMPA116 (cotton textile stained with blood, milk and ink) and EMPA17 (polyester/cotton textile stained with blood, milk and ink).
- Bacillus lentus strain 309 is deposited with the NCIB and accorded the accession number NCIB 10309, and described in U.S. Pat. No. 3,723,250 incorporated by reference herein.
- the parent subtilase 309 or Savinase® can be obtained from strain 309.
- the expression host organism is Bacillus subtilis.
- the plasmid pSX222 is used as E. coli - B. subtilis shuttle vector and B. subtilis expression vector (as described in WO 96/34946).
- Fermentations for the production of subtilase enzymes are performed at pH 7.3 and 37° C. on a rotary shaking table at 225 rpm in 50 ml tubes containing 15 ml double TY media for 2-3 days.
- the subtilase variant secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
- washing experiments are performed.
- the enzyme variants are tested using the Automatic Mechanical Stress Assay (AMSA).
- AMSA Automatic Mechanical Stress Assay
- the AMSA plate has a number of slots for test solutions and a lid firmly squeezing the textile swatch to be washed against all the slot openings.
- the plate, test solutions, textile and lid are vigorously shaken to bring the test solution in contact with the textile and apply mechanical stress.
- WO 02/42740 especially the paragraph “Special method embodiments” at pages 23-24.
- Detergents for wash performance tests of the subtilase enzymes of the invention can be obtained by purchasing fully formulated commercial detergents at the market and subsequently inactivate the enzymatic components by heat treatment (5 minutes at 85° C. in aqueous solution). Moreover a commercial detergent base without enzymes can be purchased directly from the manufacturer. Further a suitable model detergent can be composed according to the provisions at page 19-24 herein and used for wash performance tests.
- Subtilisin 309 (Savinase®) site-directed variants of the invention comprising specific insertions/deletions/substitutions are made by traditional cloning of DNA fragments (Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, 1989) produced by PCR with oligos containing the desired mutations.
- the template plasmid DNA may be pSX222, or an analogue of this containing a variant of subtilisin 309. Mutations are introduced by oligo directed mutagenesis to the construction of variants.
- the subtilisin 309 variants are transformed into E. coli .
- DNA purified from an over night culture of these transformants is transformed into B. subtilis by restriction endonuclease digestion, purification of DNA fragments, ligation, transformation of B. subtilis . Transformation of B. subtilis is performed as described by Dubnau et al., 1971, J. Mol. Biol. 56: 209-221.
- Mutagenic primers are synthesized corresponding to the DNA sequence flanking the sites of mutation, separated by the DNA base pairs defining the insertions/deletions/substitutions.
- the resulting mutagenic primers are used in a PCR reaction with the modified plasmid pSX222.
- the resulting PCR fragment is purified and extended in a second PCR-reaction, the resulting PCR product is purified and extended in a third PCR-reaction before being digested by endonucleases and cloned into the E. coli - B. subtilis shuttle vector pSX222.
- the PCR reactions are performed under normal conditions.
- the plasmid DNA is transformed into E. coli by well-known techniques and one E. coli colony is sequenced to confirm the mutation designed.
- subtilase variants of the invention In order to purify subtilase variants of the invention, the pSX222 expression plasmid comprising a variant of the invention was transformed into a competent B. subtilis strain and fermented as described above.
- HCIC Hydrophobic Charge Induction Chromatography
- the HCIC uses a cellulose matrix to which 4-Mercapto-Ethyl-Pyridine (4-MEP) is bound.
- Beads of the cellulose matrix sized 80-100 micro-m are mixed with a media containing yeast extract and the transformed B. subtilis capable of secreting the subtilisin variants and incubated at pH 9.5 in Unifilter® microplates.
- the concentration of the purified subtilisin enzyme variants is assessed by active site titration (AST).
- the purified enzyme is incubated with the high affinity inhibitor Cl-2A at different concentrations to inhibit a varying amount of the active sites.
- the protease and inhibitor binds to each other at a 1:1 ratio and accordingly the enzyme concentration can be directly related to the concentration of inhibitor, at which all protease is inactive.
- a substrate 0.6 mM Suc-Ala-Ala-Pro-Phe-pNA in Tris/HCl buffer
- pNA paranitrophenol
- Assay A Commercial detergent base Latin American type Detergent dosage 1.5-2.5 g/l Test solution volume 160 micro l pH 10-10.5 adjusted with NaHCO 3 Wash time 14 min. Temperature 20° C. Water hardness 6-9°dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material EMPA 117
- Assay B Commercial detergent base European powder type 1 Detergent dosage 6 g/l Test solution volume 160 micro I pH as it is in detergent (app. 10-10.5) Wash time 20 min. Temperature 30° C. Water hardness 6-9° dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material EMPA 116
- the performance of the enzyme variant is measured as the brightness of the colour of the textile samples washed with that specific enzyme variant. Brightness can also be expressed as the intensity of the light reflected from the textile sample when luminated with white light. When the textile is stained the intensity of the reflected light is lower, than that of a clean textile. Therefore the intensity of the reflected light can be used to measure wash performance of an enzyme variant.
- Color measurements are made with a professional flatbed scanner (PFU DL2400pro), which is used to capture an image of the washed textile samples.
- the scans are made with a resolution of 200 dpi and with an output colour dept of 24 bits.
- the scanner is frequently calibrated with a Kodak reflective IT8 target.
- a special designed software application is used (Novozymes Color Vector Analyzer).
- the program retrieves the 24 bit pixel values from the image and converts them into values for red, green and blue (RGB).
- the intensity value (Int) is calculated by adding the RGB values together as vectors and then taking the length of the resulting vector:
- wash performance (P) of the variants was calculated in accordance with the below formula:
- Int(v) is the light intensity value of textile surface washed with enzyme variant
- Int(r) is the light intensity value of textile surface washed with the reference enzyme subtilisin 309 (BLSAVI).
- Assay C Commercial detergent base European powder type 2 Detergent dosage 4 g/l Test solution volume 160 micro l pH as it is in detergent (app. 10-10.5) Wash time 20 min. Temperature 30° C. Water hardness 6-9° dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material EMPA 116
- Assay D Commercial detergent base European powder type 1 Detergent dosage 6 g/l Test solution volume 160 micro l Ph as it is in detergent (app. 10-10.5) Wash time 20 min. Temperature 30° C. Water hardness 6-9° dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material C-10 swatches from Center for Testmaterials, Vlaardingen, NL
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
Abstract
The present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: wash performance, thermal stability, storage stability or catalytic activity. The variants of the invention are suitable for use in, e.g., cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions.
Description
- This application is a divisional of U.S. application Ser. No. 10/699,394 filed on Oct. 31, 2003, which claims priority or the benefit under 35 U.S.C. 119 of Danish application nos. PA 200201705 and PA 200201933 filed on Nov. 8, 2002 and Dec. 18, 2002, respectively, and U.S. provisional application Nos. 60/427,156, 60/434,723, and 60/507,537 filed on Nov. 18, 2002, Dec. 19, 2002, and Oct. 1, 2003, respectively, the contents of which are fully incorporated herein by reference.
- 1. Technical Field
- The present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: wash performance, thermal stability, storage stability or catalytic activity. The variants of the invention are suitable for use in, e.g., cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions. The present invention also relates to isolated DNA sequences encoding the variants, expression vectors, host cells, and methods for producing and using the variants of the invention. Further, the present invention relates to cleaning and detergent compositions comprising the variants of the invention.
- 2. Description of Related
- In the detergent industry enzymes have for more than 30 years been implemented in washing formulations. Enzymes used in such formulations comprise proteases, lipases, amylases, cellulases, as well as other enzymes, or mixtures thereof. Commercially the most important enzymes are proteases.
- An increasing number of commercially used proteases are protein engineered variants of naturally occurring wild type proteases, e.g., Durazym®, Relase®, Alcalase®, Savinase®, Primase®, Duralase®, Esperase®, Ovozyme® and Kannase® (Novozymes A/S), Maxatase™, Maxacal™, Maxapem™, Properase™, Purafect™, Purafect OxP™, FN2™, FN3™ and FN4™ (Genencor International, Inc.). Further, a number of protease variants are described in the art. A thorough list of prior art protease variants is given in WO 99/27082.
- However, even though a number of useful protease variants have been described, there is still a need for new improved proteases or protease variants for a number of industrial uses such as laundry or hard surface cleaning. Therefore, an object of the present invention is to provide improved subtilase variants for such purposes.
- Thus, in a first aspect the present invention relates to a subtilase variant comprising at least
- a) an insertion, substitution or deletion of one of the amino acid residues K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S,T in one or more of the
positions 62, 68, 97, 98, 99, 106, 131, 170, 245, 252, - in combination with at least one of the following modifications
*0AQSVPWG; A1T,V; Q2L; S3T,A,L; V4L,A; I8V,T; S9G,D,R,K,L,V; R10H,K; V11A; Q12D; A13V; P14S,T,D,A,M,V,K,Q,L,H,R,I; A15M,T; A16P; H17R; N18S,H; R19W,K,L,F,G,I; G20*,R,A; L21F,LP,LW,LA,LG; T22S,A,K,TV,TG,TL,TW,TV,G,L,TY; G23S; S24P; K27R, V28I; V30I; I35T,V; T38S; P40L; N43D; R45H,K; G46D; A48T; S49N; F50S; V51A,I,D; P52V,A; P55S,A; S57P; G61E,D,S,R,GP; N62D,ND,NE,DE,NG,E,S; V68A,S,L,I; T71A; I72V; L75I; N76S,D; N77S; S78T; V81A; A85T; S87C; A88V,T; E89G; K94N; V95C,T; L96LA,LG; G97E,D,W,A,GG,GA,GV,N,GS; A98S,D,E,T,AS,AD,AV,AE,AH,Q,N,M,L,G,R,V,S; S99D,L,A,AD,SD,SM,SG,DA,P,G,N,C,M,V,I; G100S,GE,C; S101SA, SK; G102D,S; S103D,E,Y,L,Q,H,T; V104T,S,R,I,N,M,L,D; S106D,E,T,M,G,A,L,F,I; I107T,V,M; A108V,T,S; L111I,V; A114V; N116S,D; G118D; M119L,I,V,A,S; H120N,D,Q,K,E,Y,S; V121A; L124C; L126I; G127E; S128N,I,G,C; P129PSN,T,E,D,S,N,A; S130P,T,C,*; P131M,F,W,L,A,H,T,*,PA,S,Q,R,E,G,D,C; S132G,T; A133ASA; T134A; Q137H,E,D; A138G,V; V139L,I; N140D, K; T143A; S144D, N,P; R145G; V150I; A151V,G; A152P; A158T,V,C,E,L,D, M; G160A,D; S163G,C,N,A; Y167K,A,I; A168G; A169G; R170c,S,H,L; Y171C; A172V; N173D; A174V; M175L,I,V,A,S,T; N183D; N184D,S; N185S,D; R186L,C,H; S188G; S190A; Y192H; G195F,E; V203S,A,L,Q,M, F,I; N204T,D,S; Q206L; Y209C,H; G211D; S212N,L; T213A; Y214C,H; A215D,T; N218D,S; M222L,I,V,A,S; A223G; T224A,S; A228T; A230V; A232S,L,T,P; V234I; Q236A,L,D,T,C,M,F,S; K237R; N238D; P239T,S; S240F; S242T; V244I,M,A; Q245R,K,E,D,T,F,N,V,W,G,I,S,C,L,A,M; N248P,D,S; K251E,R; N252G,H,D,V,M,S,T,E,Y,S,Q,K,A,L; A254S; T255A,S; S256N,R,G; L257G; G258K, S259A,N,G; T260A,R; N261D; L262S, Q,V; Y263H,F; G264E; S265G,R,N; V268L,I; N269T; N296K; E271A; T274S,L,A,R or - b) one of the following combination variants
- A108T+L111V; L124I+S125A; P129S+S130AT; L96LA+A151G+V203A; S49N+V203L+N218D; S3T+A16P+R45C+G100S+A230V; 18V+R19K+V1391; N76D+A174AL+A194P+A230V; N185R; N62NE; H120Q+Q137E, G61GE, G61GS, G100L, A133D, V68A, N123D, L111F+Y263H, V11A+G61GE+V227A+S240F, A133E+S144K+N218D, S128A+P129S+S130SP, S9R+A15T+T22TQ+S101P, S9R+A15T+H120R+Q137D+N173S, G97E, Q245W, S9R+A15T+L96LG+Q137E+Y209H, S9R+A15T+L111V+Q137E+G211D, S9R+A15T+L111I+Q137E, S9R+A15T+L111I+H120N+Q137E, S9R+A15T+L96LG+H120Q+Q137E, S9R+A15T+T260M, S9R+A15T, Q245I, S9R+A15T+H120G+Q137E+N218D, S9R+A15T+S130P, Q245F, S9R+A15T+N218D, G63E+N76D+A194P+A230V, S9R+A15T+T224A, G100S, S9R+A15T+D60DG, A138V+V1391+A194P+N218D+A230V, A108V+A169G+R170A+Y171H, 18V+P14L+R19L+V30I+I35V+S57P+P129S+Q137D+S144D+S256N, A133D+T134S+Q137A, Q137D, A98AH, V51D, Q12E+P14L+A15T, G63E+N76D+A194P+A230V, Q12E+P14L+A15T, G97GS or
- c) one or more modifications in position 68, wherein said modification(s) comprise(s): deletion, insertion and/or substitution of an amino acid residue selected from the group consisting of K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S and T.
- In a second aspect the present invention relates to a subtilase variant comprising
- a) the combination of one or more of the modifications
- X62D,XD,XE,XG,DE
- X68A,S,L,I
- X97E,D,W,A,N,XG,XA,XV,XS
- X98S,D,E,T,XS,XD,XV
- X99D,L,A,P,G,N,AD,XD,XM,XG,DA
- X106D,E,T,M,G,A,L,F,I
- X131M,F,W,L,A,H,T,*,S,Q,R,E,G,XA
- X170C,S,H
- X245R,K,E,D,T,F,N,V,W,G,I,S,C,L,A
- X252G, H, D,V, M, S,T,E,Y,S,Q,K
- with at least one of the following modifications
*0AQSVPWG; A1T,V; Q2L; S3T,A,L; V4L,A; I8V,T; S9G,D,R,K,L,V; R10H,K; V11A; Q12D; A13V; P14S,T,D,A,M,V,K,Q,L,H,R,I; A15M,T; A16P; H17R; N18S,H; R19W,K,L,F,G,I; G20*,R,A; L21F,LP,LW,LA,LG; T22S,A,K,TV,TG,TL,TW,TV,G,L,TY; G23S; S24P; K27R, V28I; V30I; I35T,V; T38S; P40L; N43D; R45H,K; G46D; A48T; S49N; F50S; V51A,I,D; P52V,A; P55S,A; S57P; G61E,D,S,R,GP; N62D,ND,NE,DE,NG,E,S; V68A,S,L,I; T71A; I72V; L75I; N76S,D; N77S; S78T; V81A; A85T; S87C; A88V,T; E89G; K94N; V95C,T; L96LA,LG; G97E,D,W,A,GG,GA,GV,N,GS; A98S,D,E,T,AS,AD,AV,AE,AH,Q,N,M,L,G,R,V,S; S99D,L,A,AD,SD,SM,SG,DA,P,G,N,C,M,V,I; G100S,GE,C; S101SA, SK; G102D,S; S103D,E,Y,L,Q,H,T; V104T,S,R,I,N,M,L,D; S106D,E,T,M,G,A,L,F,I; I107T,V,M; A108V,T,S; L111I,V; A114V; N116S,D; G118D; M119L,I,V,A,S; H120N,D,Q,K,E,Y,S; V121A; L124C; L126I; G127E; S128N,I,G,C; P129PSN,T,E,D,S,N,A; S130P,T,C,*; P131M,F,W,L,A,H,T,*,PA,S,Q,R,E,G,D,C; S132G,T; A133ASA; T134A; Q137H,E,D; A138G,V; V139L,I; N140D, K; T143A; S144D, N,P; R145G; V150I; A151V,G; A152P; A158T,V,C,E,L,D, M; G160A,D; S163G,C,N,A; Y167K,A,I; A168G; A169G; R170c,S,H,L; Y171C; A172V; N173D; A174V; M175L,I,V,A,S,T; N183D; N184D,S; N185S,D; R186L,C,H; S188G; S190A; Y192H; G195F,E; V203S,A,L,Q,M, F,I; N204T,D,S; Q206L; Y209C,H; G211D; S212N,L; T213A; Y214C,H; A215D,T; N218D,S; M222L,I,V,A,S; A223G; T224A,S; A228T; A230V; A232S,L,T,P; V2341; Q236A,L,D,T,C,M,F,S; K237R; N238D; P239T,S; S240F; S242T; V244I,M,A; Q245R,K,E,D,T,F,N,V,W,G,I,S,C,L,A,M; N248P,D,S; K251E,R; N252G,H,D,V,M,S,T,E,Y,S,Q,K,A,L; A254S; T255A,S; S256N,R,G; L257G; G258K, S259A,N,G; T260A,R; N261D; L262S, Q,V; Y263H,F; G264E; S265G,R,N; V268L,I; N269T; N296K; E271A; T274S,L,A,R. - In a third aspect the present invention relates to a subtilase variant comprising at least one of the alterations disclosed in Table I below:
-
TABLE I subtilase variants of the inventions having one or more of the alterations: G97E + A98S V28I + A98AD + T224S G97D + A98D S99AD + M175V + P131F V95C + G97W + A98E S99AD + P131L V95T + G97A + A98D S9R + S99AD + P131W S103Y + V104M + S106D V68A + N116S + V139L + Q245R V104T + S106D S3T + A16P + R45C + G100S + A230V S3T + A16P + S99SD + S144D + A158T + A230V + I8V + S9R + A15T + R19W + V30I + G61D + S99SD + T260R S256N S103D + V104T + S106T V30I + S99SD + S256R S103D + V104L + S106M G61S + S99SD + V244I S103D + V104T + S106G V68A + V139L + S163G + N185S S103D + V104S + S106A S99SD + Y263H S103H + V104N + S106D V104N + S106T S103E + V104I + S106T S99SG + S144D S103Q + V104T + S106E V30I + S99SD S103E + S106T N18H + S99SD S103E + V104R + S106A S9R + T22S + S99SD + K251E A108T + L111V A48T + V68A + P131M L124I + S125A A15M + S99SM + V139I + V244I L124C + P131* P14T + A15M + S99SD P129S + S130AT I8V + S99SD + S144D + A228T L96LA + A151G + V203A I8V + R19K + V139I S99SD + A108V + V139L I35T + N62D S99SD + S190A N62D + S265G S99SD + V203A Q2L + N62D S99SD + V139I N62D + N76D S99SD + A108V R45H + G61E + V68A S99SD + S106A + A151G N62D + V121A V68A + S106A N62D + A215D V68A + N185D + V203S N62D + N238D V68A + V139L N62D + R145G V68A + V139I V4L + N62D + E89G V68A + A158V N62D + S188G + K251R V68A + V203A S49N + N62D V68A + V203S N62NE V68A + V203L + S259A V11A + N62DE V68A + S106L N62ND + N184S + S256G V30I + V68A + V203S N18S + N62D + I107T + A254S V51A + V68A + S106T + A168G S57P + N62ND V51A + V68A + S106T + A168G N62NE + V234I V68A + N76S + V203M + P239T Q137H + R170C + G195E V68A + V203L S99A + S101SA V68A + L75I + V203Q R10K + P14A + R19K + A98AS + S128N V68A + T71A + V139L T22A + R45K + A98AS + S128N Y192H + V68A A98AV + S99D + Y167K V68A + S106A + A108T S9G + P14K + Y167A + R170S V68A + S106T + A108T S9D + P14T + Y167A + R170S V68S + A108S S9R + P14M + A98AD V68A + N76S + G211D S9R + R19L + A98AD + E271A V68A + S106T + A108T S9R + P14S + R19F + A98AD A151V + R170C S99DA + P129PSN + P131A P14D + A98AS + H120D + G195F + S212N + S99AD + V244M + Q245K + N248D + K251R + M222S T255A + S256N S49N + V203L + N218D S9R + P14V + R19G + A98AD V68A + S106M + N184D S99AD + N248P + T255A + S256G P55S + V68L + A158E + G160A *0AQSVPWG + A98AD V68A + A158C T22A + S99AD V68A + A158L + Y214C K94N + A98T + S99L A88V + S99AD + P131F N76D + A174AL + A194P + A230V P14T + A16P + I72V + S99SD + V244I + T260A P40L + N218D + A232S + Q236L + Q245E + S259N S99AD + P131F A232L + Q236D + Q245E R10H + N62D A232T + Q236L + Q245D V28I + A98AD + T224S R170H + Q236A + Q245R S9K + T22K + S99AD A232L + Q236T + Q245D P14S + S99AD + P131W G97GG + P131H + Q137E + V268L V68A + I72V + P131F A88V + G97GV + P131H S9R + S99AD G97GA + H120Q + S130P + G264E S9K + S99AD G97GG + V139L V28I + A88V + G100S + P131M G97GG + Q137D S103L + V104S + S106G G97GG + H120D + Q137H V68A + T224A N185R V68A + P131F P131H + Q137E A48T + V68A + P131M V104I + H120N + P131H + Q137E V68A + I72V + P131F H120Q + Q137E G100GE + P131F S9R + A15T + G97GV + H120D S99AD + P131F + T260A G100S + H120Q + Q137H R19G + A98AS V68A + H120K + Q137E G61R + N62D G97GA + H120E V68A + S106M + N184D H120D + S128I + Q137D P55S + V68L + A158E + G160A G97GG + P131H V68A + A158C G97GG + H120N + L126I R19W + G61S + S99SD + N204T + Y263H + S9R + A15T + G97GA + H120D + P131H + S265R Q137E A232T + Q236C S9R + A15T + G97GV + P131T + Q137H N62D + A232T + Q236C S9R + A15T + G20* + L21F + N62D + Q245N A232P + Q236L + Q245E S9L + A15T + T22TV + V139L + Q245F A232S + Q236L + Q245T + K251E S132G + Q245F S163C + Q236M + Q245T + S256G S9R + A15T + T22TG + N62D + V139L + Q245V N218D + A232L + Q236F + Q245F S9L + A15T + T22TV + V139L + Q245F + L262S S163N + A232L + Q236S + Q245E S9R + A15T + T22TL + N62D + Q245W A232S + Q236S + Q245E V68A + A158L + Y214C V68A + V203L N62D + V150I V68S + A158D S3T + P14Q + A15M + R19K + N62D + S144D I8V + A15T + R19K + A85T + S99SD + A114V + P14Q + R19W + V51I + G61E + S99SD + V139I + V244I + S256N + Y263H T260R L111F + Y263H S3T + P14L + H17R + S99SD + V139I + S144D P52V + S78T + S99SD S3A + V30I + S99SD + S106G + N248S A15M + S99SD + V268I I8V + A15T + S99SD S99G + S128N + N183D + A232L + Q236T + S3T + S9R + P14H + A15M + R19L + S99SD + Q245R V139I S99R + S101SA S9R + A15T + G97GG + H120D + Q137E L96LA + A98T + P131AA S9R + A15T + G20A + G97GV + H120D + P131H A98E + S99P S163N + A232L + Q236A + Q245G V28I + S99AD + P131F N173D + A232L + Q236A + Q245N S9R + A15T + G97GV + Q137H P55S + V68A + S106M + A108T + P129T V81A + P131T + A133S + Q137E K27R + V68L + G118D + A158E N43D + V68A + S106F + N238D A98E + S99A + S101SK V68A + V203F V68A + N140D + T143A + S144N V68A + S106E N62D + N140K + T143A + S144D V68A + S106I S9F + P14T + R19L + A98AD V68A + A158M + R170C S9V + P14R + R19F + A98AD V68A + P129T + N218D S99A + S99SD + G258K + L262Q V68S + P129E S87C + S99SA + S99D + P131A V68S + P129D S99A + S99SD + G258K + L262Q V68L + P129E + N261D V28I + S99A + *99aD + P131F G97GV + H120D A85T + G102D + S106T + K237R P131A + A133ASA V68A + T71A L111F + Y263H G61GS V11A + G61GE + V227A + S240F G100L A133E + S144K + N218D A133D S128A + P129S + S130SP V68A G61GE N123D S9R + A15T + T22TW + N204D + Q245I Q245W + N252V S9R + A15T + G97GG + P131S + Q137H R45H + Y171C + Q245W + N252S S9R + A15T + T22TG + N62D + V139L + Q245G G20R + A48T + R170C + Q245W + N252Q S9R + A15T + T22TL + N62D + I107V + V139L + S9R + A15T + A16P + G97GA + P131S + Q137D + Q245W N204S S9G + A15T + G97GA + Q137H N218D + Q245W + N252E S9R + A15T + V68A + Q245R G20R + R170C + Q245R + N252V S9R + A15T + G97GA + H120N + S212L S9R + P14I + R19K + A98AD + T274S S9R + A15T + L96LG + H120D + P131H + R186L A98AE + V203I S9R + A15T + G97GA + H120D + Q137D V51A + V68A + S163G + V203A N62D + N252T N62D + Q245W + N252H V4A + S9R + A15T + G97GV + H120D N62D + Q245W + N252A S9R + A15T + G97GV + H120D + Q137H G20R + N62D + V244I + Q245W + N252E S9R + A15T + L96LG + H120N + P131H + Q137E N204D + Q245S S9R + A15T + L96LG + H120D + P131S + Q137E N62D + Q245W + N252E S9R + A15T + H120N + P131T + N218D N62D + Q245R + N252V S9R + A15T + L21LP + T22TV + M119I + N218D + S9R + A15T + S24P + G61E + A85T + P239S + Q245I Q245A S9R + A15T + L96LG + H120D + G160D G102S + M222S + Q245L + N252D V68A + S106A + G118D + Q245R + T255S + A15M + V30I + N62D + S99N + L111I + V244A + L257G + T274L S265N S9R + A15T + G61E + A85T + P239L + Q245C S9R + A15T + T22TG + N62D + V139L + Q245S S9R + A15T + P131H + S144P S3T + Q12D + R19W + V30I + S106G + I107M S9R + A15T + G97GA + Q137E V68A + A88T + V139L S9R + A15T + G97GA + H120Q + P131H + Q137E V51I + L111I + G118D + Q245R S9R + A15T + L21LW + G100S + V139L + Q245V V68A + V203L S9R + A15T + G97GA + Q137H + N218S A1T + V68A + N116D + G118D S9R + A15T + L96LG + H120N + P131S + Q137H V68A + G118D + Q245R S9R + A15T + G97GA + H120N + Q137E N62D + V139I + N183D + N185S + V203I + Q245R + L262S S9R + A15T + L96LG + P131T + Q137H N62D + I72V S9R + A15T + L96LG + H120N + P131S N62D + V81A + Q245R S9R + A15T + V68A + Q137D T22A + V68A + S106T + G118D S9R + A15T + G97GA + H120Y + Q137H V68A + L111I + V203I S9R + A15T + G97GA + Q137D G61E + V68A + A169G S9R + A15T + K94N + H120N + P131H V68A + L111V S9R + A15T + L96LG + P131H + Q137D V68A + G118D + V203A + K251R S9R + A15T + F50S + H120D + P131H V68A + G118D S9R + A15T + G97GA + H120N + Q137D + N248D A1V + V51A + V68A + V203I S9R + A15T + L96LG + P131Q + Q137D V68A + V139L + A223G S9R + A15T + T22G + V139L + Q245L N62D + Y214H + K237R V139L + Q245R V68A + S106A + G118D + Q245R S9R + A15T + Q245F S9R + A15T + T22A + N62D S9R + A15T + Q245S A98Q + S99D S9R + A15T + G97GV + H120Q S9R + P14I + R19K + A98AD S9R + A15T + G97GA + Q137E + L262V S9R + A15M + A16P + T22S + S99AD S9R + A15T + G127E + P131R + Q137H S99AD + T255R + S256N S9R + A13V + A15T + I35V + N6D + Q245F S9R + A15T + T22TQ + S101P S9R + A15T + Q245V S9R + A15T + H120R + Q137D + N173S V139L + Q245F G97E S9R + A15T + T22A + V139L + Q245E Q245W S9R + A15T + T22L + V139L + Q245V + A254S S9R + A15T + L96LG + Q137E + Y209H S9R + R19L + A98AD S9R + A15T + L111V + Q137E + G211D P14R + A98AD S9R + A15T + L111I + Q137E S9R + A15T + Q245L S9R + A15T + L111I + H120N + Q137E S9R + A15T + G61E + A85T + P239S + Q245V S9R + A15T + L96LG + H120Q + Q137E S9R + A15T + G61E + A85T + Q206L + Q245R S9R + A15T + T260M P239T + Q245R S9R + A15T S9R + A15T + N62NG + Q245T Q245I S9R + A15T + G61GP + Q245L S9R + A15T + H120G + Q137E + N218D S9R + A15T + G61E + A85T + Q137H + Y209C + I8V + P14L + R19L + V30I + I35V + S57P + P129S + Q245G Q137D + S144D + S256N S9R + A15T + G61E + A85T + P239S + Q245C Q245F V68I + A98AD S9R + A15T + N218D V68A + N269K G63E + N76D + A194P + A230V N62D + Q245A + N252G + S265G S9R + A15T + T224A N218D + Q245G + N252H G100S S9R + A15T + G102S + M175T + Q245R + N252D S9R + A15T + D60DG S9R + A15T + N62D + Q245W + N252V A138V + V139I + A194P + N218D + A230V S9R + A15T + N62D + Q245R + N252M A108V + A169G + R170A + Y171H S9R + A15T + N62D + Q245W + N252S S9R + A15T + S130P S99SD + N204S + Q245R A133D + T134S + Q137A N62D + Q245R Q137D N62D + A151G A98AH V68A + S106T V51D S99A + S99SD + V203L Q12E + P14L + A15T A98AD + A215T G63E + N76D + A194P + A230V N62D + Q245G + N252T Q12E + P14L + A15T A152P + Q245R + N252T G97GS S163N + T213A + Q245R Q245W + N252Y S106L + Q245R + N252E A169G + R170H S9V + P14R + R19F + A98AD Q12E + P14L + A15T S9R + A15T + L111I + Q137E P14R + A98AD S9R + A15T + G97GA + Q137E G100S S9R + A15T + L96LG + Q137E + Y209H A169G + R170H S9R + A15T + L96LG + H120N + P131S A98AD + A169G S9R + A15T + G97GV + H120Q A138V + V139I + A194P + N218D + A230V S9R + A15T + L96LG + H120Q + Q137E S99A + S99SD + V203L S9R + A15T + G97GV + P131S V68A + S106T S9R + A15T + K94N + H120N + P131H A98AD + A215T S9R + A15T + N76S + L111V + P131H + Q137D A108V + A169G + R170A + Y171H S9R + A15T + F50S + H120D + P131H S3L + N62D + S163A + S190A S9R + A15T + L96LG + S130* S9R + P14I + R19K + A98AD + T274S S9R + A15T + T22TL + N62D + I107V + V139L + S9R + A15T + G61E + A85T + N218D + P239S + Q245W Q245L S9R + A15T + G97GA + H120D + Q137H + S9R + A15T + S24P + G61E + A85T + P239S + M222V Q245A S9R + A15T + G97GA + H120N + Q137D + N248D S99SD + P131F S9R + A15T + L21LW + G100S + V139L + Q245V N62D + P131F + A172V S9R + A15T + G20* + L21F + N62D + Q245N N62D + P131F S9R + A15T + L21LC + V139L + R186H + Q245M V68A + A88T + V139L S132G + Q245 V68A + G118D + V203A S9R + A15T + T22TG + N62D + V139L + Q245G P40L + V68A + A108T + A138V + V203I S9R + A15T + L96LG + P131Q + Q137D I8T + A98AD + T274R S9R + A15T + T22TQ + S101P A98AE + V203I S9R + A15T + T22TG + N62D + V139L + Q245V V51A + V68A + S163G + V203A S9R + A15T + T22TL + N62D + Q245W A1V + V51A + V68A + V203I S9R + A15T + T22TW + N204D + Q245I V68A + G100S S9R + A15T + T22TG + N62D + V139L + Q245S V68A + V203L S9R + A15T + S130P A1T + V68A + N116D + G118D Q245W N62D + A169G + V203I + Q245R S9R + A15T + L21LP + T22TY + V139L + G160D + G23S + S99SD + A194P + S242T + Q245R + Q245L T274R S9R + A15T + G61E + A85T + P239L + Q245C S99SD + N204S + Q245R S9R + A15T + L21LP + T22TV + M119I + N218D + N62D + V139I + N183D + N185S + V203I + Q245I Q245R + L262S S9R + A15T + V68A + Q245R V68A + S106A + G118D + Q245R S9R + A15T + T22A + V139L + Q245E V51I + L111I + G118D + Q245R V139L + Q245R N62D + Q245R S9R + A15T + Q245F N62D + I72V S9R + A15T + Q245S S9R + R19L + A98AD S9R + A15T + T260M S9G + P14R + R19I + A98AD S9R + A15T S9R + A15T + T22L + V139L + Q245V + A254S S9R + A15T + L21LG + T22TV + V139L + N204D + S99G + S128N + N183D + A232L + Q236T + Q245N Q245R V139L + Q245F S9R + A15T + Q245L S9R + A15T + T22G + V139L + Q245L S9R + A15T + N62NG + Q245T S9R + A15T + Q245V S9R + A15T + N62ND + V139L + Q245E Q245F S9R + A15T + N62ND + V139L + N261D S9R + Q245C Y167I + R170L + Q245E S9R + A15T + N218D Y167I + R170L + Q245R S9R + A13V + A15T + I35V + N62D + Q245F Y167I + R170L + Q245M S9R + A15T + T224A Y167I + R170L S163N + A232L + Q236A + Q245G S99SE + Q245R S9R + A15T + A16P + G97GA + P131S + Q137D + S9R + A15T + G61E + A85T + Q137H + Y209C + N204S Q245G N218D + A232L + Q236F + Q245F S9R + A15T + G61E + A85T + P239S + Q245C S163N + A232L + Q236S + Q245E G102S + M222S + Q245L + N252D G97GA + H120E N62D + Q245A + N252G + S265G G97GG + P131H N62D + Q245G + N252T S9R + A15T + G97GA + H120D + P131H + Q137E S9R + A15T + N62D + Q245W + N252V S9R + A15T + G97GV + Q137H S9R + A15T + N62D + Q245R + N252M S9R + A15T + G97GV + H120N S9R + A15T + N62D + Q245W + N252S S9R + A15T + G97GG + P131S + Q137H S163N + T213A + Q245R S9R + A15T + G97GG + H120N + Q137D S106L + Q245R + N252E S9R + A15T + H120Q + P131C + Q137H Q245W + N252Y S9R + A15T + G97GV + H120D + Q137H Q245W + N252V S163C + Q236M + Q245T + S256G G20R + A48T + R170C + Q245W + N252Q S9R + A15T + G97GG + H120D + P131H + N62D + N252T Q137H S9R + A15T + G97GV + H120E + Q137H N218D + Q245W + N252E S9R + A15T + G97GV + P131T + Q137H G20R + R170C + Q245R + N252V S9R + A15T + G97GV +0 H120Q + Y263F N62D + Q245W + N252H S9R + A15T + G97GV + S106A + P131H N62D + Q245W + N252A S9R + A15T + G97GG + L111I + P131T + Q137H G20R + N62D + V244I + Q245W + N252E S9R + A15T + G97GV + P131H + Q137H N204D + Q245S S9R + A15T + G20A + G97GV + H120D + P131H N62D + Q245W + N252E S9R + A15T + G97GA + H120D + P131S + Q137E N62D + Q245R + N252V S9G + A15T + G97GA + Q137H A98L + S99C + Q245R S9R + A15T + H120R + Q137D + N173S N62D + A98R + Q245R S9R + A15T + L96LG + H120N + P131H + Q137E S9R + A15T + V68A + S99G + Q245R + N261D S9R + A15T + L96LG + H120D + P131S + Q137E S9R + A15T + G20* + L21F + N62D + Q245R S9R + A15T + H120N + P131T + N218D S9R + A15T + G20* + L21F + N62E + Q245R S9R + A15T + G97GA + H120D + Q137D V68I + A98AD S9R + A15T + L96LG + H120D + P131H + R186L S9R + A15T + H120D + Q137D S9R + A15T + G97GA + R186C S9R + A15T + N77S + L96LG + H120D + P131Q V4A + S9R + A15T + G97GV + H120D S9R + A15T + G97GA + H120N + Q137E S9R + A15T + L96LG + H120D + G160D S9R + A15T + G97GA + Q137E + L262V S9R + A15T + G97GA + H120N + S212L S9R + A15T + P131H + S144P S9R + A15T + G97GA + Q137H + N218S S9R + A15T + G127E + P131R + Q137H M222S + Q245G + N252G S9R + A15T + V68A + S99G + Q245R + N261D V68I + V203L N62D + P131F + A172V V51A + S163T N62D + P131F S106A + A138G S99SD + Q245R V139I + A151G S9R + A13T + S99A + S99SD + P131F A98R + G100C + Q245R S9R + A15T + N62S + H120N + P131T + N218D S9R + A15T + S99G + G100S + H120N + P131S + S9R + A15T + S99C + H120N + P131S + Q137H + Q137H M222S A15T + N185D + M222S + Q245R + N252V A98G + S99C + Q245R S9R + A15T + T22TL + G61E + L96LG + Q137D + A98T + S99G + G100S + S240F + Q245R Q245R S9R + T22TL + G61E + G97GG + M119I + P131T S9R + A15T + H120N + P131T + N218D + N269T Y209H + M222S + Q245G + N252L M222S + Q245M + N252E S9R + A15T + G61E + H120S + Q137D + V139L + S9R + A15T + L96LG + H120N + P131S + Q137H + N218D M222S S9R + A15T + N62D + H120N + P131T S9R + A15T + G61E + A98S + S99M + Q245R S9R + A15T + V68A + N218D + Q245R A98G + G100S + Q245R + N261D S9R + A15T + V68A + H120N + N218D + Q245R S9R + A15T + V68A + A98L + Q245R S9R + A15T + V68A + A174V + Q245R S9R + A15T + V68A + A98G + S99V + Q245R S9R + A15T + G46D + V68A + N218D + Q245R S9R + A15T + V68A + A98M + Q245R + N248D G97D + A98N + S128G + S130T + P131D + T134A S9R + A15T + G61E + V68A + A98S + S99G + Q245R S9R + A15T + V68A + A98M + S99G + Q245R + S9R + A15T + A88V + A98R + S99G + G100C + T274A H120N + P131S + Q137H S9R + A15T + V68A + A98L + S99G + Q245R A98V + S99C + Q245R S9R + A15T + A98 + S99C + H120N + P131S + S9R + A15T + G20* + L21F + G61E + *61aP + Q137H Q245R S9R + A15T + T38S + A98R + S99C + G100S + S9R + A15T + V68A + A98G + S99I + K237R + H120N + P131S + Q137H Q245R S9R + A15T + A98C + G100S + H120N + P131S + S9R + A15T + V68A + H120N + P131S + Q137H + Q137H Q245R S9R + A15T + A98S + G100S + H120N + P131S + S9R + A15T + V68A + H120D + P131S + Q137H + Q137H Q245R S9R + A15T + G20* + L21F + N62D + Q245R A98S + S99G + G100S + Q245R S9R + A15T + G20* + L21F + N62D + Q245R + S9R + A15T + A98S + S99G + G100S + H120N + S259G P131S + Q137H A98S + G100S + Q245R A98T + S99G + G100S + Q245R S9R + A15T + G20* + L21F + *61aA + V68A + S9R + A15T + G20* + L21F + P52T + N62D + Q245R Q245R S9R + A15T + G20* + L21F + N62E + Q245R A98L + S99C + Q245R V68A + S105G + S106A V68A + S106A + T213A S9R + A15T + Y167I + R170L S9R + A15T + V68A V68A + S106A + N252M + Y263C V68A + S106A + Q245W V68A + S106A + Q245R + N252D V68A + S106A + Q245W + N252K V68A + S106A + A174V + Q245R + N252D S9R + A15T + V68A + Q245R + N252S S9R + A15T + V28I + V68A + Q245R + N252A S9R + A15T + V68A + A194T + Q245R + N252E S9R + A15T + G20* + L21F + *63aG + Q245R + S9R + A15T + G20* + L21F + *62aS + N218D + N272V Q245R S9R + A15T + G20* + L21F + *61aS + V68A + S9R + A15T + V68A + H120N + P131S + Q137H + G160D + Q245R Q245M
wherein - (a) the variant of Table I exhibits protease activity, and
- (b) each position corresponds to a position of the amino acid sequence of subtilisin BPN′, shown in
FIG. 1 and SEQ ID NO: 1. - In a fourth aspect the present invention relates to an isolated polynucleotide encoding a subtilase variant of the invention.
- In a fifth aspect the present invention relates to an expression vector comprising the isolated polynucleotide of the invention.
- In a sixth aspect the present invention relates to a microbial host cell transformed with the expression vector of the invention.
- In a seventh aspect the present invention relates to a method for producing a subtilase variant according to the invention, wherein a host according to the invention is cultured under conditions conducive to the expression and secretion of the variant, and the variant is recovered.
- In an eighth aspect the present invention relates to a cleaning or detergent composition, preferably a laundry or dish wash composition, comprising the variant of the invention.
- In a ninth aspect the present invention relates to a subtilase variant comprising at least one of the alterations disclosed in Table II below:
-
TABLE II subtilase variants of the inventions having one or more of the alterations: G97GA + H120D + P131H + Q137E L111I + Q137E G97GV + Q137H G97GA + Q137H + N218S T22TQ + S101P L96LG + H120N + P131S + Q137H G97GV + H120D + Q137H L96LG + H120N + P131S + Q137H V4A + G97GV + H120D G97GA + H120N + Q137E L111V + Q137E + G211D L111I + H120N + Q137E L21LW + G100S + V139L + Q245V L96LG + P131T + Q137H V68A + Q137D L96LG + H120N + P131S L96LG + H120Q + Q137E G97GA + H120Y + Q137H K94N + H120N + P131H G97GA + Q137D G97GV + H120Q L96LG + P131H + Q137D G97GA + Q137E + L262V F50S + H120D + P131H D60DG G97GA + H120N + Q137D + N248D T22TL + N62D + Q245W L96LG + P131Q + Q137D T22TW + N204D + Q245I T22G + V139L + Q245L T22TG + N62D + V139L + Q245V Q245F G97GG + P131S + Q137H Q245S G20* + L21F + N62D + Q245N T260M T22TG + N62D + V139L + Q245G H120G + Q137E + N218D T22TL + N62D + I107V + V139L + Q245W G127E + P131R + Q137H G97GG + H120D + Q137E S130P H120R + Q137D + N173S Q245V V68A + Q245R N218D G97GA + H120N + S212L T22A + V139L + Q245E G97GA + H120N + S212L T22L + V139L + Q245V + A254S L96LG + H120D + P131H + R186L T224A G97GA + H120D + Q137D Q245L S9R + A15T + A16P + G97GA + P131S + Q137D + G61E + A85T + P239S + Q245V N204S L21LP + T22TV + M119I + N218D + Q245I G61E + A85T + Q206L+ Q245R L96LG + H120N + P131H + Q137E N62NG + Q245T L96LG + H120D + P131S + Q137E G61GP + Q245L H120N + P131T + N218D G61E + A85T + Q137H + Y209C + Q245G L96LG + H120D + G160D G61E + A85T + P239S + Q245C T22TG + N62D + V139L + Q245S G102S + M175T + Q245R + N252D G61E + A85T + P239L + Q245C N62D + Q245W + N252V G61E + A85T + P239L + Q245C N62D + Q245R + N252M P131H + S144P N62D + Q245W + N252S G97GA + Q137E S24P + G61E + A85T + P239S + Q245A L96LG + Q137E + Y209H T22A + N62D G97aA + H120Q + P131H + Q137E L111I + Q137E G61E + A85T + N218D + P239S + Q245L G97GA + Q137E S24P + G61E + A85T + P239S + Q245A L96LG + Q137E + Y209H T22L + V139L + Q245V + A254S L96LG + H120N + P131S T224A G97GV + H120Q Q245L L96LG + H120Q + Q137E N62NG + Q245T G97GV + P131S N62ND + V139L + Q245E K94N + H120N + P131H N62ND + V139L + N261D N76S + L111V + P131H + Q137D G61E + A85T + Q137H + Y209C + Q245G F50S + H120D + P131H G61E + A85T + P239S + Q245C L96LG + S130* N62D + Q245W + N252V L96LG + P131Q + Q137D N62D + Q245R + N252M G97GA + H120D + Q137H + M222V N62D + Q245W + N252S G97GA + H120N + Q137D + N248D V68A + S99G + Q245R + N261D L21LW + G100S + V139L + Q245V G20* + L21F + N62D + Q245R G20* + L21F + N62D + Q245N G20* + L21F + N62E + Q245R L21LC + V139L + R186H + Q245M H120D + Q137D T22TG + N62D + V139L + Q245G N77S + L96LG + H120D + P131Q T22TL + N62D + I107V + V139L + Q245W G97GA + H120N + Q137E T22TQ + S101P G97GA + Q137E + L262V T22TG + N62D + V139L + Q245V P131H + S144P T22TL + N62D + Q245W G127E + P131R + Q137H T22TW + N204D + Q245I G97GG + H120D + P131H + Q137H T22TG + N62D + V139L + Q245S G97GV + H120E + Q137H L21LP + T22TY + V139L + G160D + Q245L G97GV + P131T + Q137H S130P G97GV + H120Q + Y263F G61E + A85T + P239L + Q245C G97GV + S106A + P131H L21LP + T22TV + M119I + N218D + Q245I G97GG + L111I + P131T + Q137H V68A + Q245R G97GV + P131H + Q137H T22A + V139L + Q245E G20A + G97GV + H120D + P131H Q245F G97GA + H120D + P131S + Q137E Q245S G97GA + Q137H T260M H120R + Q137D + N173S S9R + A15T L96LG + H120N + P131H + Q137E L21LG + T22TV + V139L + N204D + Q245N L96LG + H120D + P131S + Q137E T22G + V139L + Q245L H120N + P131T + N218D Q245V G97GA + H120D + Q137D N218D G97GG + P131S + Q137H A13V + I35V + N62D + Q245F G97GG + H120N + Q137D G97GA + H120D + P131H + Q137E H120Q + P131C + Q137H G97GV + Q137H G97GV + H120D + Q137H G97GV + H120N A16P + G97GA + P131S + Q137D + N204S L96LG + H120D + P131H + R186L L96LG + H120D + G160D G97GA + R186C G97GA + H120N + S212L V4A + G97GV + H120D G97GA + Q137H + N218S G20* + L21F + *63aG + Q245R + N272V V68A + H120N + P131S + Q137H + Q245M G20* + L21F + *61aA + V68A + Q245R V28I + V68A + Q245R + N252A V68A + A194T + Q245R + N252E V68A + Q245R + N252S G20* + L21F + *62aS + N218D + Q245R G20* + L21F + *61aS + V68A + G160D + Q245R
wherein - (a) the variant of Table II exhibits protease activity, and
- (b) each position corresponds to a position of the amino acid sequence of subtilisin BPN′, shown in
FIG. 1 and SEQ ID NO: 1. - In a tenth aspect the present invention relates to a subtilase variant comprising one of the alterations N252D and N252M.
- In an eleventh aspect the present invention relates to a subtilase variant comprising one or more of the alterations M119L, I, V, A, S; M175L, I, V, A, S and M222L, I, V, A, S in combination with the subtilase variants listed in tables I and II above.
- Concerning alignment and numbering, reference is made to
FIG. 1 which shows an alignment between subtilisin BPN′ (a) (BASBPN) and subtilisin 309 (b) (BLSAVI). This alignment is in this patent application used as a reference for numbering the residues. - Prior to discussing this invention in further detail, the following terms and conventions will first be defined.
- For a detailed description of the nomenclature of amino acids and nucleic acids, we refer to WO 00/71691 beginning at page 5, hereby incorporated by reference.
- In describing the various subtilase enzyme variants produced or contemplated according to the invention, the following nomenclatures and conventions have been adapted for ease of reference:
- A frame of reference is first defined by aligning the isolated or parent enzyme with subtilisin BPN′ (BASBPN).
- The alignment can be obtained by the GAP routine of the GCG package version 9.1 to number the variants using the following parameters: gap creation penalty=8 and gap extension penalty=8 and all other parameters kept at their default values.
- Another method is to use known recognized alignments between subtilases, such as the alignment indicated in WO 91/00345. In most cases the differences will not be of any importance.
- Thereby a number of deletions and insertions will be defined in relation to BASBPN (SEQ ID NO.1). In
FIG. 1 , subtilisin 309 (SEQ ID NO.2) has 6 deletions in positions 36, 58, 158, 162, 163, and 164 in comparison to BASBPN. These deletions are inFIG. 1 indicated by asterixes (*). - For a detailed description of the nomenclature of modifications introduced in a polypeptide by genetic manipulation we refer to WO 00/71691 page 7-12, hereby incorporated by reference.
- Enzymes cleaving the amide linkages in protein substrates are classified as proteases, or (interchangeably) peptidases (see Walsh, 1979, Enzymatic Reaction Mechanisms. W.H. Freeman and Company, San Francisco, Chapter 3).
- If nothing else is mentioned the amino acid numbering used herein correspond to that of the subtilase BPN′ (BASBPN) sequence. For further description of the BPN′ sequence, see
FIG. 1 , SEQ ID NO: 1 or Siezen et al., 1991, Protein Engng. 4: 719-737. - A serine protease is an enzyme which catalyzes the hydrolysis of peptide bonds, and in which there is an essential serine residue at the active site (White, Handler and Smith, 1973 “Principles of Biochemistry,” Fifth Edition, McGraw-Hill Book Company, NY, pp. 271-272).
- The bacterial serine proteases have molecular weights in the 20,000 to 45,000 Dalton range. They are inhibited by diisopropylfluorophosphate. They hydrolyze simple terminal esters and are similar in activity to eukaryotic chymotrypsin, also a serine protease. A more narrow term, alkaline protease, covering a sub-group, reflects the high pH optimum of some of the serine proteases, from pH 9.0 to 11.0 (for review, see Priest, 1977, Bacteriological Rev. 41: 711-753).
- A sub-group of the serine proteases tentatively designated subtilases has been proposed by Siezen et al., 1991, Protein Engng. 4: 719-737 and Siezen et al., 1997, Protein Science 6: 501-523. They are defined by homology analysis of more than 170 amino acid sequences of serine proteases previously referred to as subtilisin-like proteases. A subtilisin was previously often defined as a serine protease produced by Gram-positive bacteria or fungi, and according to Siezen et al. now is a subgroup of the subtilases. A wide variety of subtilases have been identified, and the amino acid sequence of a number of subtilases has been determined. For a more detailed description of such subtilases and their amino acid sequences reference is made to Siezen et al. (1997).
- One subgroup of the subtilases, I-S1 or “true” subtilisins, comprises the “classical” subtilisins, such as subtilisin 168 (BSS168), subtilisin BPN′, subtilisin Carlsberg (ALCALASE®, NOVOZYMES A/S), and subtilisin DY (BSSDY).
- A further subgroup of the subtilases, I-S2 or high alkaline subtilisins, is recognized by Siezen et al. (supra). Sub-group I-S2 proteases are described as highly alkaline subtilisins and comprises enzymes such as subtilisin PB92 (BAALKP) (MAXACAL®, Genencor International Inc.), subtilisin 309 (SAVINASE®, NOVOZYMES A/S), subtilisin 147 (BLS147) (ESPERASE®, NOVOZYMES A/S), and alkaline elastase YaB (BSEYAB).
- SAVINASE® is marketed by NOVOZYMES A/S. It is subtilisin 309 from B. lentus and differs from BAALKP only in one position (N87S). SAVINASE® has the amino acid sequence designated b) in
FIG. 1 and in SEQ ID NO: 2. - The term “parent subtilase” describes a subtilase defined according to Siezen et al. (1991 and 1997). For further details see description of “Subtilases” above. A parent subtilase may also be a subtilase isolated from a natural source, wherein subsequent modifications have been made while retaining the characteristic of a subtilase. Furthermore, a parent subtilase may be a subtilase which has been prepared by the DNA shuffling technique, such as described by J. E. Ness et al., 1999, Nature Biotechnology 17: 893-896.
- Alternatively the term “parent subtilase” may be termed “wild type subtilase”.
- For reference a table of the acronyms for various subtilases mentioned herein is provided, for further acronyms, see Siezen et al., 1991, Protein Engng. 4: 719-737 and Siezen et al., 1997, Protein Science 6: 501-523.
-
TABLE III Organism Bacteria: Gram-positive enzyme acronym Bacillus subtilis 168 subtilisin I168, apr BSS168 Bacillus amyloliquefaciens subtilisin BPN′ (NOVO) BASBPN Bacillus subtilis DY subtilisin DY BSSDY Bacillus licheniformis subtilisin Carlsberg BLSCAR Bacillus lentus subtilisin 309 BLSAVI Bacillus lentus subtilisin 147 BLS147 Bacillus alcalophilus PB92 subtilisin PB92 BAPB92 Bacillus YaB alkaline elastase YaB BYSYAB Thermoactinomyces vulgaris thermitase TVTHER - The term “modification(s)” used herein is defined to include chemical modification of a subtilase as well as genetic manipulation of the DNA encoding a subtilase. The modification(s) can be replacement(s) of the amino acid side chain(s), substitution(s), deletion(s) and/or insertions in or at the amino acid(s) of interest.
- In the context of this invention, the term subtilase variant or mutated subtilase means a subtilase that has been produced by an organism which is expressing a mutant gene derived from a parent microorganism which possessed an original or parent gene and which produced a corresponding parent enzyme, the parent gene having been mutated in order to produce the mutant gene from which said mutated subtilase protease is produced when expressed in a suitable host.
- The homology between two amino acid sequences is in this context described by the parameter “identity”.
- In order to determine the degree of identity between two subtilases the GAP routine of the GCG package version 9.1 can be applied (infra) using the same settings. The output from the routine is besides the amino acid alignment the calculation of the “Percent Identity” between the two sequences.
- Based on this description it is routine for a person skilled in the art to identify suitable homologous subtilases, which can be modified according to the invention.
- The term “isolated”, when applied to a polynucleotide, denotes that the polynucleotide has been removed from its natural genetic milieu and is thus free of other extraneous or unwanted coding sequences, and is in a form suitable for use within genetically engineered protein production systems. Such isolated molecules are those that are separated from their natural environment and include cDNA and genomic clones. Isolated DNA molecules of the present invention are free of other genes with which they are ordinarily associated, but may include naturally occurring 5′ and 3′ untranslated regions such as promoters and terminators. The identification of associated regions will be evident to one of ordinary skill in the art (see for example, Dynan and Tijan, 1985, Nature 316: 774-78). The term “an isolated polynucleotide” may alternatively be termed “a cloned polynucleotide”.
- When applied to a protein, the term “isolated” indicates that the protein has been removed from its native environment. In a preferred form, the isolated protein is substantially free of other proteins, particularly other homologous proteins (i.e., “homologous impurities” (see below)).
- An isolated protein is more than 10% pure, preferably more than 20% pure, more preferably more than 30% pure, as determined by SDS-PAGE. Further it is preferred to provide the protein in a highly purified form, i.e., more than 40% pure, more than 60% pure, more than 80% pure, more preferably more than 95% pure, and most preferably more than 99% pure, as determined by SDS-PAGE.
- The term “isolated protein” may alternatively be termed “purified protein”.
- The term “homologous impurities” means any impurity (e.g., another polypeptide than the subtilase of the invention), which originate from the homologous cell where the subtilase of the invention is originally obtained from.
- The term “obtained from” as used herein in connection with a specific microbial source, means that the polynucleotide and/or subtilase produced by the specific source, or by a cell in which a gene from the source has been inserted.
- The term “substrate” used in connection with a substrate for a protease should be interpreted in its broadest form as comprising a compound containing at least one peptide (amide) bond susceptible to hydrolysis by a subtilisin protease.
- The term “product” used in connection with a product derived from a protease enzymatic reaction should, in the context of the present invention, be interpreted to include the products of a hydrolysis reaction involving a subtilase protease. A product may be the substrate in a subsequent hydrolysis reaction.
- In the present context the term “wash performance” is used as an enzyme's ability to remove proteinaceous or organic stains present on the object to be cleaned during, e.g., wash or hard surface cleaning. See also the wash performance test in Example 3 herein.
-
FIG. 1 shows an alignment between subtilisin BPN′ (a) and Savinase® (b) using the GAP routine mentioned above. - The present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: wash performance, thermal stability, storage stability or catalytic activity.
- Variants which are contemplated as being part of the invention are such variants where, when compared to the wild-type subtilase, one or more amino acid residues has been substituted, deleted or inserted, said variants comprising at least a) an insertion, substitution or deletion of one of the amino acid residues K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S,T in one or more of the
positions 62, 68, 97, 98, 99, 106, 131, 170, 245, 252, - in combination with at least one of the following modifications
*0AQSVPWG; A1T,V; Q2L; S3T,A,L; V4L,A; I8V,T; S9G,D,R,K,L,V; R10H,K; V11A; Q12D; A13V; P14S,T,D,A,M,V,K,Q,L,H,R,I; A15M,T; A16P; H17R; N18S,H; R19W,K,L,F,G,I; G20*,R,A; L21F,LP,LW,LA,LG; T22S,A,K,TV,TG,TL,TW,TV,G,L,TY; G23S; S24P; K27R, V28I; V30I; I35T,V; T38S; P40L; N43D; R45H,K; G46D; A48T; S49N; F50S; V51A,I,D; P52V,A; P55S,A; S57P; G61E,D,S,R,GP; N62D,ND,NE,DE,NG,E,S; V68A,S,L,I; T71A; I72V; L75I; N76S,D; N77S; S78T; V81A; A85T; S87C; A88V,T; E89G; K94N; V95C,T; L96LA,LG; G97E,D,W,A,GG,GA,GV,N,GS; A98S,D,E,T,AS,AD,AV,AE,AH,Q,N,M,L,G,R,V,S; S99D,L,A,AD,SD,SM,SG,DA,P,G,N,C,M,V,I; G100S,GE,C; S101SA, SK; G102D,S; S103D,E,Y,L,Q,H,T; V104T,S,R,I,N,M,L,D; S106D,E,T,M,G,A,L,F,I; I107T,V,M; A108V,T,S; L111I,V; A114V; N116S,D; G118D; M119L,I,V,A,S; H120N,D,Q,K,E,Y,S; V121A; L124C; L126I; G127E; S128N,I,G,C; P129PSN,T,E,D,S,N,A; S130P,T,C,*; P131M,F,W,L,A,H,T,*,PA,S,Q,R,E,G,D,C; S132G,T; A133ASA; T134A; Q137H,E,D; A138G,V; V139L,I; N140D, K; T143A; S144D, N,P; R145G; V150I; A151V,G; A152P; A158T,V,C,E,L,D, M; G160A,D; S163G,C,N,A; Y167K,A,I; A168G; A169G; R170c,S,H,L; Y171C; A172V; N173D; A174V; M175L,I,V,A,S,T; N183D; N184D,S; N185S,D; R186L,C,H; S188G; S190A; Y192H; G195F,E; V203S,A,L,Q,M, F,I; N204T,D,S; Q206L; Y209C,H; G211D; S212N,L; T213A; Y214C,H; A215D,T; N218D,S; M222L,I,V,A,S; A223G; T224A,S; A228T; A230V; A232S,L,T,P; V234I; Q236A,L,D,T,C,M,F,S; K237R; N238D; P239T,S; S240F; S242T; V244I,M,A; Q245R,K,E,D,T,F,N,V,W,G,I,S,C,L,A,M; N248P,D,S; K251E,R; N252G,H,D,V,M,S,T,E,Y,S,Q,K,A,L; A254S; T255A,S; S256N,R,G; L257G; G258K, S259A,N,G; T260A,R; N261D; L262S, Q,V; Y263H,F; G264E; S265G,R,N; V268L,I; N269T; N296K; E271A; T274S,L,A,R or - b) one of the following combination variants
- A108T+L111V; L124I+S125A; P129S+S130AT; L96LA+A111G+V203A; S49N+V203L+N218D; S3T+A16P+R45C+G100S+A230V; I8V+R19K+V139I; N76D+A174AL+A194P+A230V; N185R; N62NE; H120Q+Q137E, G61GE, G61GS, G100L, A133D, V68A, N123D, L111F+Y263H, V11A+G61GE+V227A+S240F, A133E+S144K+N218D, S128A+P129S+S130SP, S9R+A15T+T22TQ+S101P, S9R+A15T+H120R+Q137D+N173S, G97E, Q245W, S9R+A15T+L96LG+Q137E+Y209H, S9R+A15T+L111V+Q137E+G211D, S9R+A15T+L111I+Q137E, S9R+A15T+L111I+H120N+Q137E, S9R+A15T+L96LG+H120Q+Q137E, S9R+A15T+T260M, S9R+A15T, Q245I, S9R+A15T+H120G+Q137E+N218D, S9R+A15T+S130P, Q245F, S9R+A15T+N218D, G63E+N76D+A194P+A230V, S9R+A15T+T224A, G100S, S9R+A15T+D60DG, A138V+V1391+A194P+N218D+A230V, A108V+A169G+R170A+Y171H, I8V+P14L+R19L+V30I+I35V+S57P+P129S+Q137D+S144D+S256N, A133D+T134S+Q137A, Q137D, A98AH, V51D, Q12E+P14L+A15T, G63E+N76D+A194P+A230V, Q12E+P14L+A15T, G97GS or
- c) one or more modifications in position 68, wherein said modification(s) comprise(s): deletion, insertion and/or substitution of an amino acid residue selected from the group consisting of K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S and T.
- Further, variants of the present invention comprises at least one or more of the alterations indicated in Table I and II, wherein
- (a) the variants of Table I and II has protease activity, and
- (b) each position corresponds to a position of the amino acid sequence of subtilisin
- BPN′ (SEQ ID NO: 1).
- A subtilase variant of the first aspect of the invention may be a parent or wild-type subtilase identified and isolated from nature. Such a parent wild-type subtilase may be specifically screened for by standard techniques known in the art.
- One preferred way of doing this may be by specifically PCR amplifying conserved DNA regions of interest from subtilases from numerous different microorganism, preferably different Bacillus strains.
- Subtilases are a group of conserved enzymes, in the sense that their DNA and amino acid sequences are homologous. Accordingly it is possible to construct relatively specific primers flanking the polynucleotide sequences of interest.
- Using such PCR primers to amplify DNA from a number of different microorganisms, preferably different Bacillus strains, followed by DNA sequencing of said amplified PCR fragments, it will be possible to identify strains which produce subtilase variants of the invention.
- Having identified the strain and a partial DNA sequence of such a subtilase of interest, it is routine work for a person skilled in the art to complete cloning, expression and purification of such a subtilase. However, it is envisaged that a subtilase variant of the invention is predominantly a variant of a parent subtilase.
- A subtilase variant suitable for the uses described herein may be constructed by standard techniques known in the art such as by site-directed/random mutagenesis or by DNA shuffling of different subtilase sequences. See the “Material and Methods” section and Example 1 herein (vide infra) for further details.
- As will be acknowledged by the skilled person, the variants described herein may comprise one or more further modifications, in particular one or more further substitutions or insertions. Moreover, the variants described herein may encompass mutation at more than just one position. For example the variant according to the invention may contain mutations at one position, two positions, three positions or more than three positions, such as four to eight positions.
- It is preferred that the parent subtilase belongs to the subgroups I-S1 or I-S2, especially subgroup I-S2, both for enzymes from nature or from the artificial creation of diversity, and for designing and producing variants from a parent subtilase.
- In relation to variants from subgroup I-S1, it is preferred to select a parent subtilase from the group consisting of BSS168 (BSSAS, BSAPRJ, BSAPRN, BMSAMP), BASBPN, BSSDY, BLSCAR (BLKERA, BLSCA1, BLSCA2, BLSCA3), BSSPRC, and BSSPRD, or functional variants thereof having retained the characteristic of sub-group I-S1.
- In relation to variants from subgroup I-S2 it is preferred to select a parent subtilase from the group consisting of BSAPRQ, BLS147 (BSAPRM, BAH101), BLSAVI (BSKSMK, BAALKP, BLSUBL), BYSYAB, BAPB92, TVTHER, and BSAPRS, or functional variants thereof having retained the characteristic of sub-group I-S2.
- In particular, the parent subtilase is BLSAVI (Savinase®, NOVOZYMES A/S), and a preferred subtilase variant of the invention is accordingly a variant of Savinase®.
- The present invention also encompasses any of the above mentioned subtilase variants in combination with any other modification to the amino acid sequence thereof. Especially combinations with other modifications known in the art to provide improved properties to the enzyme are envisaged. The art describes a number of subtilase variants with different improved properties and a number of those are mentioned in the “Background of the invention” section herein (vide supra). Those references are disclosed here as references to identify a subtilase variant, which advantageously can be combined with a subtilase variant described herein.
- Such combinations comprise the positions: 222 (improves oxidation stability), 218 (improves thermal stability), substitutions in the Ca2+-binding sites stabilizing the enzyme, e.g., position 76, and many other apparent from the prior art.
- In further embodiments a subtilase variant described herein may advantageously be combined with one or more modification(s) in any of the positions:
- 27, 36, 56, 76, 87, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 120, 123, 159, 167, 170, 206, 218, 222, 224, 232, 235, 236, 245, 248, 252 and 274.
- Specifically, the following BLSAVI, BLSUBL, BSKSMK, and BAALKP modifications are considered appropriate for combination:
- K27R, *36D, S56P, N62D, V68A, N76D, S87N, G97N, S99SE, S101G, S103A, V104A, V104I, V104N, V104Y, S106A, H120D, H120N, N123S, G159D, Y167A, R170S, R170L, A194P, N204D, V205I, Q206E, L217D, N218S, N218D, M222S, M222A, T224S, A232V, K235L, Q236H, Q245R, N248D, N252K and T274A.
- Furthermore variants comprising any of the modifications K27R+V104Y+N123S+T274A, N76D+S103A+V104I, N76D+V104A, S87N+S101G+V104N, S99D+S101R+S103A+V104I+G160S, S3T+V4I+S99D+S101R+S103A+V104I+G160S+A194P+V199M+V205I+L217D, S3T+V4I+S99D+S101R+S103A+V104I+G160S+V199M+V205I+L217D, S3T+V4I+S99D+S101R+S103A+V104I+G160S+V205I, S101G+V104N, or other combinations of the modifications K27R, *36D, S56P, N62D, V68A, N76D, S87N, G97N, S99SE, S101G, S103A, V104A, V104I, V104N, V104Y, S106A, H120D, H120N, N123S, G159D, Y167A, R170S, R170L, A194P, N204D, V205I, Q206E, L217D, N218S, N218D, M222A, M222S, T224S, A232V, K235L, Q236H, Q245R, N248D, N252K and T274A in combination with any one or more of the modification(s) mentioned above exhibit improved properties.
- A particular interesting variant is a variant, which, in addition to modifications according to the invention, contains the following substitutions:
- Moreover, subtilase variants of the main aspect(s) of the invention are preferably combined with one or more modification(s) in any of the positions 129, 131 and 194, preferably as 129K, 131H and 194P modifications, and most preferably as P129K, P131H and A194P modifications. Any of those modification(s) are expected to provide a higher expression level of the subtilase variant in the production thereof.
- The wash performance of a selected variant of the invention may be tested in the wash performance test disclosed in Example 3 herein. The wash performance test may be employed to assess the ability of a variant, when incorporated in a standard or commercial detergent composition, to remove proteinaceous stains from a standard textile as compared to a reference system, namely the parent subtilase or a similar subtilase exhibiting an even better wash performance (incorporated in the same detergent system and tested under identical conditions). The enzyme variants of the present application were tested using the Automatic Mechanical Stress Assay (AMSA). With the AMSA test the wash performance of a large quantity of small volume enzyme-detergent solutions can be examined rapidly. Using this test, the wash performance of a selected variant can be initially investigated, the rationale being that if a selected variant does not show a significant improvement in the test compared to the parent subtilase, it is normally not necessary to carry out further test experiments.
- Therefore, variants which are particularly interesting for the purposes described herein, are such variants which, when tested in a commercial detergent composition such as a US type detergent, an Asian type, a European type or a Latin American type detergent as described in the wash performance test (Example 3), shows an improved wash performance as compared to the parent subtilase tested under identical conditions.
- The improvement in the wash performance may be quantified by calculating the so-called intensity value (Int) defined in Example 3, herein.
- In a very interesting embodiment of the invention, the variant of the invention, when tested in the wash performance test has a Performance Score (S) of at least 1, preferably a Performance Score of 2, where:
- S (2)=variant performs better than the reference at all three enzyme concentrations (5, and 30 nM),
- S (1)=variant performs better than the reference at one or two concentrations.
- Evidently, it is preferred that the variant of the invention fulfils the above criteria on at least the stated lowest level, more preferably at the stated highest level.
- Many methods for cloning a subtilase and for introducing substitutions, deletions or insertions into genes (e.g., subtilase genes) are well known in the art.
- In general standard procedures for cloning of genes and introducing mutations (random and/or site directed) into said genes may be used in order to obtain a subtilase variant of the invention. For further description of suitable techniques reference is made to Example 1 herein (vide infra) and (Sambrook et al., 1989, Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, N.Y.; Ausubel, F. M. et al. (eds.) “Current protocols in Molecular Biology”. John Wiley and Sons, 1995; Harwood, C. R., and Cutting, S. M. (eds.) “Molecular Biological Methods for Bacillus”. John Wiley and Sons, 1990), and WO 96/34946.
- Further, a subtilase variant may be constructed by standard techniques for artificial creation of diversity, such as by DNA shuffling of different subtilase genes (WO 95/22625; Stemmer, 1994, Nature 370: 389-91). DNA shuffling of, e.g., the gene encoding Savinase® with one or more partial subtilase sequences identified in nature, will after subsequent screening for improved wash performance variants, provide subtilase variants suitable for the purposes described herein.
- A recombinant expression vector comprising a DNA construct encoding the enzyme of the invention may be any vector that may conveniently be subjected to recombinant DNA procedures.
- The choice of vector will often depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomously replicating vector, i.e., a vector that exists as an extra-chromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid.
- Alternatively, the vector may be one that on introduction into a host cell is integrated into the host cell genome in part or in its entirety and replicated together with the chromosome(s) into which it has been integrated.
- The vector is preferably an expression vector in which the DNA sequence encoding the enzyme of the invention is operably linked to additional segments required for transcription of the DNA. In general, the expression vector is derived from plasmid or viral DNA, or may contain elements of both. The term, “operably linked” indicates that the segments are arranged so that they function in concert for their intended purposes, e.g., transcription initiates in a promoter and proceeds through the DNA sequence coding for the enzyme.
- The promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
- Examples of suitable promoters for use in bacterial host cells include the promoter of the Bacillus stearothermophilus maltogenic amylase gene, the Bacillus licheniformis alpha-amylase gene, the Bacillus amyloliquefaciens alpha-amylase gene, the Bacillus subtilis alkaline protease gene, or the Bacillus pumilus xylosidase gene, or the phage Lambda PR or PL promoters or the E. coli lac, trp or tac promoters.
- The DNA sequence encoding the enzyme of the invention may also, if necessary, be operably connected to a suitable terminator.
- The recombinant vector of the invention may further comprise a DNA sequence enabling the vector to replicate in the host cell in question. The vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the host cell, or a gene encoding resistance to, e.g., antibiotics like kanamycin, chloramphenicol, erythromycin, tetracycline, spectinomycine, or the like, or resistance to heavy metals or herbicides.
- To direct an enzyme of the present invention into the secretory pathway of the host cells, a secretory signal sequence (also known as a leader sequence, prepro sequence or pre sequence) may be provided in the recombinant vector. The secretory signal sequence is joined to the DNA sequence encoding the enzyme in the correct reading frame. Secretory signal sequences are commonly positioned 5′ to the DNA sequence encoding the enzyme. The secretory signal sequence may be that normally associated with the enzyme or may be from a gene encoding another secreted protein.
- The procedures used to ligate the DNA sequences coding for the present enzyme, the promoter and optionally the terminator and/or secretory signal sequence, respectively, or to assemble these sequences by suitable PCR amplification schemes, and to insert them into suitable vectors containing the information necessary for replication or integration, are well known to persons skilled in the art (cf., for instance, Sambrook et al., op.cit.).
- The DNA sequence encoding the present enzyme introduced into the host cell may be either homologous or heterologous to the host in question. If homologous to the host cell, i.e., produced by the host cell in nature, it will typically be operably connected to another promoter sequence or, if applicable, another secretory signal sequence and/or terminator sequence than in its natural environment. The term “homologous” is intended to include a DNA sequence encoding an enzyme native to the host organism in question. The term “heterologous” is intended to include a DNA sequence not expressed by the host cell in nature. Thus, the DNA sequence may be from another organism, or it may be a synthetic sequence.
- The host cell into which the DNA construct or the recombinant vector of the invention is introduced may be any cell that is capable of producing the present enzyme and includes bacteria, yeast, fungi and higher eukaryotic cells including plants.
- Examples of bacterial host cells which, on cultivation, are capable of producing the enzyme of the invention are gram-positive bacteria such as strains of Bacillus, such as strains of B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. coagulans, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. stearothermophilus, B. subtilis, or B. thuringiensis, or strains of Streptomyces, such as S. lividans or S. murinus, or gram-negative bacteria such as Escherichia coli.
- The transformation of the bacteria may be effected by protoplast transformation, electroporation, conjugation, or by using competent cells in a manner known per se (cf. Sambrook et al., supra).
- When expressing the enzyme in bacteria such as E. coli, the enzyme may be retained in the cytoplasm, typically as insoluble granules (known as inclusion bodies), or may be directed to the periplasmic space by a bacterial secretion sequence. In the former case, the cells are lysed and the granules are recovered and denatured after which the enzyme is refolded by diluting the denaturing agent. In the latter case, the enzyme may be recovered from the periplasmic space by disrupting the cells, e.g., by sonication or osmotic shock, to release the contents of the periplasmic space and recovering the enzyme.
- When expressing the enzyme in gram-positive bacteria such as Bacillus or Streptomyces strains, the enzyme may be retained in the cytoplasm, or may be directed to the extracellular medium by a bacterial secretion sequence. In the latter case, the enzyme may be recovered from the medium as described below.
- The present invention provides a method of producing an isolated enzyme according to the invention, wherein a suitable host cell, which has been transformed with a DNA sequence encoding the enzyme, is cultured under conditions permitting the production of the enzyme, and the resulting enzyme is recovered from the culture.
- When an expression vector comprising a DNA sequence encoding the enzyme is trans-formed into a heterologous host cell it is possible to enable heterologous recombinant production of the enzyme of the invention. Thereby it is possible to make a highly purified subtilase composition, characterized in being free from homologous impurities.
- The medium used to culture the transformed host cells may be any conventional medium suitable for growing the host cells in question. The expressed subtilase may conveniently be secreted into the culture medium and may be recovered there-from by well-known procedures including separating the cells from the medium by centrifugation or filtration, precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
- The enzyme of the invention may be added to and thus become a component of a detergent composition. In general, cleaning and detergent compositions are well described in the art and reference is made to WO 96/34946; WO 97/07202; WO 95/30011 for further description of suitable cleaning and detergent compositions.
- The detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
- In a specific aspect, the invention provides a detergent additive comprising the enzyme of the invention. The detergent additive as well as the detergent composition may comprise one or more other enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
- In general the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
- Proteases: Suitable proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included. The protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease. Examples of alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279). Examples of trypsin-like proteases are trypsin (e.g., of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
- Examples of useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
- Preferred commercially available protease enzymes include Durazym®, Relase®, Alcalase®, Savinase®, Primase®, Duralase®, Esperase®, Ovozyme® and Kannase® (Novozymes A/S), Maxatase™, Maxacal™, Maxapem™, Properase™, Purafect™, Purafect OXP™, FN2™, FN3™ and FN4™ (Genencor International, Inc.).
- Lipases: Suitable lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g., from H. lanuginosa (T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g., from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1,372,034), P. fluorescens, Pseudomonas sp. strain SD 705 (WO 95/06720 and WO 96/27002), P. wisconsinensis (WO 96/12012), a Bacillus lipase, e.g., from B. subtilis (Dartois et al., 1993, Biochemica et Biophysica Acta 1131: 253-360), B. stearothermophilus (JP 64/744992) or B. pumilus (WO 91/16422).
- Other examples are lipase variants such as those described in WO 92/05249, WO 94/01541, EP 407 225,
EP 260 105, WO 95/35381, WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202. - Preferred commercially available lipase enzymes include Lipex®, Lipolase® and Lipolase Ultra® (Novozymes A/S).
- Amylases: Suitable amylases (alpha and/or beta) include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, e.g., a special strain of B. licheniformis, described in more detail in GB 1,296,839.
- Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391, 408, and 444.
- Commercially available amylases are Duramyl®, Termamyl®, Fungamyl® and BAN® (Novozymes A/S), Rapidase™ and Purastar™ (from Genencor International Inc.).
- Cellulases: Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Acremonium, Bacillus, Humicola, Fusarium, Pseudomonas, Thielavia, e.g., the fungal cellulases produced from Fusarium oxysporum, Humicola insolens, and Myceliophthora thermophila disclosed in U.S. Pat. Nos. 4,435,307, 5,648,263, 5,691,178, and 5,776,757 and WO 89/09259.
- Especially suitable cellulases are the alkaline or neutral cellulases having colour care benefits. Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940. Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, U.S. Pat. No. 5,457,046, U.S. Pat. No. 5,686,593, U.S. Pat. No. 5,763,254, WO 95/24471, WO 98/12307 and PCT/DK98/00299.
- Commercially available cellulases include Celluzyme®, and Carezyme® (Novozymes A/S), Clazinase™, and Puradax HAT™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).
- Peroxidases/Oxidases: Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g., from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include Guardzyme® (Novozymes A/S).
- The detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes. A detergent additive of the invention, i.e., a separate additive or a combined additive, can be formulated, e.g., as a granulate, a liquid, a slurry, etc. Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
- Non-dusting granulates may be produced, e.g., as disclosed in U.S. Pat. Nos. 4,106,991 and 4,661,452 and may optionally be coated by methods known in the art. Examples of waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids. Examples of film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591. Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods. Protected enzymes may be prepared according to the method disclosed in EP 238,216.
- The detergent composition of the invention may be in any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid. A liquid detergent may be aqueous, typically containing up to 70% water and 0-30% organic solvent, or non-aqueous.
- The detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic. The surfactants are typically present at a level of from 0.1% to 60% by weight.
- When included therein the detergent will usually contain from about 1% to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
- When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanol-amide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
- The detergent may contain 0-65% of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylene-diaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenyl-succinic acid, soluble silicates or layered silicates (e.g., SKS-6 from Hoechst).
- The detergent may comprise one or more polymers. Examples are carboxymethyl-cellulose, poly(vinylpyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinyl-pyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as poly-acrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
- The detergent may contain a bleaching system which may comprise a H2O2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate. Alternatively, the bleaching system may comprise peroxyacids of, e.g., the amide, imide, or sulfone type.
- The detergent may also contain other conventional detergent ingredients such as, e.g., fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
- Variations in local and regional conditions, such as water hardness and wash temperature calls for regional detergent compositions. Detergent Examples 1 and 2 provide ranges for the composition of a typical Latin American detergent and a typical European powder detergent respectively.
-
-
Group Subname Content Surfactants 0-30% Sulphonates 0-30% Sulphates 0-5% Soaps 0-5% Non-ionics 0-5% Cationics 0-5% FAGA 0-5% Bleach 0-20% SPT/SPM 0-15% NOBS, TAED 0-5% Builders 0-60% Phosphates 0-30% Zeolite 0-5% Na2OSiO2 0-10% Na2CO3 0-20% Fillers 0-40% Na2SO4 0-40% Others up to 100% Polymers Enzymes Foam regulators Water Hydrotropes Others -
-
Group Subname Content Surfactants 0-30% Sulphonates 0-20% Sulphates 0-15% Soaps 0-10% Non-ionics 0-10% Cationics 0-10% Other 0-10% Bleach 0-30% SPT/SPM 0-30% NOBS + TAED 0-10% Builders 0-60% Phosphates 0-40% Zeolite 0-40% Na2OSiO2 0-20% Na2CO3 0-20% Fillers 0-40% Na2SO4 0-40% NaCl 0-40% Others up to 100% Polymers Enzymes Foam regulators Water Hydrotropes Others - The enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in, e.g., WO 92/19709 and WO 92/19708.
- It is at present contemplated that in the detergent compositions any single enzyme, in particular the enzyme of the invention, may be added in an amount corresponding to 0.01-200 mg of enzyme protein per liter of wash liquor, preferably 0.05-50 mg of enzyme protein per liter of wash liquor, in particular 0.1-10 mg of enzyme protein per liter of wash liquor.
- The enzyme of the invention may additionally be incorporated in the detergent formulations disclosed in WO 97/07202 which is hereby incorporated as reference.
- Standard textile pieces are obtained from EMPA St. Gallen, Lerchfeldstrasse 5, CH-9014 St. Gallen, Switzerland. Especially type EMPA116 (cotton textile stained with blood, milk and ink) and EMPA17 (polyester/cotton textile stained with blood, milk and ink).
- Bacillus lentus strain 309 is deposited with the NCIB and accorded the accession number NCIB 10309, and described in U.S. Pat. No. 3,723,250 incorporated by reference herein. The parent subtilase 309 or Savinase® can be obtained from strain 309. The expression host organism is Bacillus subtilis.
- The plasmid pSX222 is used as E. coli-B. subtilis shuttle vector and B. subtilis expression vector (as described in WO 96/34946).
- Unless otherwise mentioned the DNA manipulations and transformations are performed using standard methods of molecular biology (Sambrook et al., 1989, Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, N.Y.; Ausubel, F. M. et al. (eds.) “Current protocols in Molecular Biology”. John Wiley and Sons, 1995; Harwood, C. R., and Cutting, S. M. (eds.) “Molecular Biological Methods for Bacillus”. John Wiley and Sons, 1990).
- Unless otherwise mentioned all enzymes for DNA manipulations, such as, e.g., restriction endonucleases, ligases etc., are obtained from New England Biolabs, Inc. Enzymes for DNA manipulations are used according to the specifications of the suppliers.
- Fermentations for the production of subtilase enzymes are performed at pH 7.3 and 37° C. on a rotary shaking table at 225 rpm in 50 ml tubes containing 15 ml double TY media for 2-3 days.
- For a description of TY media, see page 1.1.3, Media Preparation and Bacteriological Tools in “Current protocols in Molecular Biology”. John Wiley and Sons, 1995; Harwood, C. R., and Cutting, S. M. (eds.).
- The subtilase variant secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
- In order to assess the wash performance of selected subtilase variants in detergent compositions, washing experiments are performed. The enzyme variants are tested using the Automatic Mechanical Stress Assay (AMSA). With the AMSA test the wash performance of a large quantity of small volume enzyme-detergent solutions can be examined. The AMSA plate has a number of slots for test solutions and a lid firmly squeezing the textile swatch to be washed against all the slot openings. During the washing time, the plate, test solutions, textile and lid are vigorously shaken to bring the test solution in contact with the textile and apply mechanical stress. For further description see WO 02/42740 especially the paragraph “Special method embodiments” at pages 23-24.
- Detergents for wash performance tests of the subtilase enzymes of the invention can be obtained by purchasing fully formulated commercial detergents at the market and subsequently inactivate the enzymatic components by heat treatment (5 minutes at 85° C. in aqueous solution). Moreover a commercial detergent base without enzymes can be purchased directly from the manufacturer. Further a suitable model detergent can be composed according to the provisions at page 19-24 herein and used for wash performance tests.
- Subtilisin 309 (Savinase®) site-directed variants of the invention comprising specific insertions/deletions/substitutions are made by traditional cloning of DNA fragments (Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, 1989) produced by PCR with oligos containing the desired mutations.
- The template plasmid DNA may be pSX222, or an analogue of this containing a variant of subtilisin 309. Mutations are introduced by oligo directed mutagenesis to the construction of variants.
- The subtilisin 309 variants are transformed into E. coli. DNA purified from an over night culture of these transformants is transformed into B. subtilis by restriction endonuclease digestion, purification of DNA fragments, ligation, transformation of B. subtilis. Transformation of B. subtilis is performed as described by Dubnau et al., 1971, J. Mol. Biol. 56: 209-221.
- The overall strategy used to perform site-directed mutagenesis is:
- Mutagenic primers (oligonucleotides) are synthesized corresponding to the DNA sequence flanking the sites of mutation, separated by the DNA base pairs defining the insertions/deletions/substitutions.
- Subsequently, the resulting mutagenic primers are used in a PCR reaction with the modified plasmid pSX222. The resulting PCR fragment is purified and extended in a second PCR-reaction, the resulting PCR product is purified and extended in a third PCR-reaction before being digested by endonucleases and cloned into the E. coli-B. subtilis shuttle vector pSX222. The PCR reactions are performed under normal conditions. The plasmid DNA is transformed into E. coli by well-known techniques and one E. coli colony is sequenced to confirm the mutation designed.
- Each of the variants listed in Table I at page 2 herein can be constructed as described above.
- In order to purify subtilase variants of the invention, the pSX222 expression plasmid comprising a variant of the invention was transformed into a competent B. subtilis strain and fermented as described above.
- After fermentation purification of subtilisin variants is accomplished using Hydrophobic Charge Induction Chromatography (HCIC) and subsequent vacuum filtration.
- To capture the enzyme, the HCIC uses a cellulose matrix to which 4-Mercapto-Ethyl-Pyridine (4-MEP) is bound.
- Beads of the cellulose matrix sized 80-100 micro-m are mixed with a media containing yeast extract and the transformed B. subtilis capable of secreting the subtilisin variants and incubated at pH 9.5 in Unifilter® microplates.
- As 4-MEP is hydrophobic at pH>7 and the subtilisin variants are hydrophobic at pH 9.5 a hydrophobic association is made between the secreted enzyme and the 4-MEP on the beads. After incubation the media and cell debris is removed by vacuum filtration while the beads and enzyme are kept on the filter.
- To elute the enzyme from the beads the pH is now lowered by washing the filter with an elution buffer (pH 5). Hereby the enzymes part from the beads and can be retrieved from the buffer.
- The concentration of the purified subtilisin enzyme variants is assessed by active site titration (AST).
- The purified enzyme is incubated with the high affinity inhibitor Cl-2A at different concentrations to inhibit a varying amount of the active sites. The protease and inhibitor binds to each other at a 1:1 ratio and accordingly the enzyme concentration can be directly related to the concentration of inhibitor, at which all protease is inactive. To measure the residual protease activity, a substrate (0.6 mM Suc-Ala-Ala-Pro-Phe-pNA in Tris/HCl buffer) is added after the incubation with inhibitor and during the following 4 minutes the development of the degradation product pNA (paranitrophenol) is measured periodically at 405 nm on an Elisa Reader.
- Each of the variants of the invention listed in Table I herein was purified according to the above procedure and subsequently the enzyme concentration was determined.
- Known concentrations of the variants of Table I were tested for wash performance in detergents as described below.
- In order to assess the wash performance of selected subtilase variants in a commercial detergent base composition, washing experiments was performed. The enzyme variants of the present application were tested using the Automatic Mechanical Stress Assay (AMSA). With the AMSA test the wash performance of a large quantity of small volume enzyme-detergent solutions can be examined. The AMSA plate has a number of slots for test solutions and a lid firmly squeezing the textile swatch to be washed against all the slot openings. During the washing time, the plate, test solutions, textile and lid are vigorously shaken to bring the test solution in contact with the textile and apply mechanical stress. For further description see WO 02/42740 especially the paragraph “Special method embodiments” at pages 23-24.
- Two assays were conducted under the experimental conditions specified below:
-
Assay A Commercial detergent base Latin American type Detergent dosage 1.5-2.5 g/l Test solution volume 160 micro l pH 10-10.5 adjusted with NaHCO3 Wash time 14 min. Temperature 20° C. Water hardness 6-9°dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material EMPA 117 - The Latin American type detergent was composed according to the provisions in Detergent Example 1 at page 24 herein. Water hardness was adjusted to 6-9° dH by addition of CaCl2 and MgCl2 (Ca2+:Mg2+=4:1) to the test system. After washing the textile pieces were flushed in tap water and air-dried.
-
Assay B Commercial detergent base European powder type 1Detergent dosage 6 g/l Test solution volume 160 micro I pH as it is in detergent (app. 10-10.5) Wash time 20 min. Temperature 30° C. Water hardness 6-9° dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material EMPA 116 - The European powder type detergent was composed according to the provisions in Detergent Example 2 at page 24 herein. Water hardness was adjusted to 15° dH by addition of CaCl2*2H2O; MgCl2*6H2O; NaHCO3 (Ca2+:Mg2+:HCO3−=4:1:10) to the test system. After washing the textile pieces were flushed in tap water and air-dried.
- The performance of the enzyme variant is measured as the brightness of the colour of the textile samples washed with that specific enzyme variant. Brightness can also be expressed as the intensity of the light reflected from the textile sample when luminated with white light. When the textile is stained the intensity of the reflected light is lower, than that of a clean textile. Therefore the intensity of the reflected light can be used to measure wash performance of an enzyme variant.
- Color measurements are made with a professional flatbed scanner (PFU DL2400pro), which is used to capture an image of the washed textile samples. The scans are made with a resolution of 200 dpi and with an output colour dept of 24 bits. In order to get accurate results, the scanner is frequently calibrated with a Kodak reflective IT8 target.
- To extract a value for the light intensity from the scanned images, a special designed software application is used (Novozymes Color Vector Analyzer). The program retrieves the 24 bit pixel values from the image and converts them into values for red, green and blue (RGB). The intensity value (Int) is calculated by adding the RGB values together as vectors and then taking the length of the resulting vector:
-
Int=√{square root over (r2 +g 2 +b 2)} - The wash performance (P) of the variants was calculated in accordance with the below formula:
-
P=Int(v)−Int(r) - where
- Int(v) is the light intensity value of textile surface washed with enzyme variant and
- Int(r) is the light intensity value of textile surface washed with the reference enzyme subtilisin 309 (BLSAVI).
- The results presented in Table IV and V below are Performance Scores (S) summing up the performances (P) of the tested enzyme variants as:
- S (2) which indicates that the variant performs better than the reference at all three concentrations (5, 10 and 30 nM) and
- S (1) which indicates that the variant performs better than the reference at one or two concentrations.
-
TABLE IV Wash performance test results, Assay A. Mutations Score Mutations Score G97E + A98S 2 V28I + A98AD + T224S 2 G97D + A98D 2 S99AD + M175V + P131F 1 V95C + G97W + A98E 2 S99AD + P131L 2 V95T + G97A + A98D 2 S9R + S99AD + P131W 1 S103Y + V104M + S106D 1 V68A + N116S + V139L + Q245R 2 V104T + S106D 2 S3T + A16P + R45C + G100S + A230V 2 S3T + A16P + S99SD + S144D + 2 I8V + S9R + A15T + R19W + V30I + G61D + 2 A158T + A230V + T260R S99SD + S256N S103D + V104T + S106T 1 V30I + S99SD + S256R 2 S103D + V104L + S106M 2 G61S + S99SD + V244I 2 S103D + V104T + S106G 2 V68A + V139L + S163G + N185S 2 S103D + V104S + S106A 2 S99SD + Y263H 2 S103H + V104N + S106D 2 V104N + S106T 2 S103E + V104I + S106T 1 S99SG + S144D 1 S103Q + V104T + S106E 2 V30I + S99SD 1 S103E + S106T 2 N18H + S99SD 2 S103E + V104R + S106A 2 S9R + T22S + S99SD + K251E 1 A108T + L111V 2 A48T + V68A + P131M 2 L124I + S125A 1 A15M + S99SM + V139I + V244I 2 L124C + P131* 2 P14T + A15M + S99SD 2 P129S + S130AT 2 I8V + S99SD + S144D + A228T 2 L96LA + A151G + V203A 1 I8V + R19K + V139I 2 S99SD + A108V + V139L 2 I35T + N62D 2 S99SD + S190A 2 N62D + S265G 2 S99SD + V203A 2 Q2L + N62D 2 S99SD + V139I 1 N62D + N76D 2 S99SD + A108V 2 R45H + G61E + V68A 2 S99SD + S106A + A151G 2 N62D + V121A 2 V68A + S106A 2 N62D + A215D 2 V68A + N185D + V203S 2 N62D + N238D 2 V68A + V139L 2 N62D + R145G 2 V68A + V139I 2 V4L + N62D + E89G 2 V68A + A158V 2 N62D + S188G + K251R 2 V68A + V203A 2 S49N + N62D 2 V68A + V203S 2 N62NE 2 V68A + V203L + S259A 2 V11A + N62DE 2 V68A + S106L 2 N62ND + N184S + S256G 2 V30I + V68A + V203S 2 N18S + N62D + I107T + A254S 2 V51A + V68A + S106T + A168G 1 S57P + N62ND 2 V51A + V68A + S106T + A168G 1 N62NE + V234I 2 V68A + N76S + V203M + P239T 2 Q137H + R170C + G195E 1 V68A + V203L 2 S99A + S101SA 2 V68A + L75I + V203Q 2 R10K + P14A + R19K + A98AS + S128N 2 V68A + T71A + V139L 2 T22A + R45K + A98AS + S128N 2 Y192H + V68A 2 A98AV + S99D + Y167K 2 V68A + S106A + A108T 2 S9G + P14K + Y167A + R170S 2 V68A + S106T + A108T 2 S9D + P14T + Y167A + R170S 2 V68S + A108S 2 S9R + P14M + A98AD 1 V68A + N76S + G211D 2 S9R + R19L + A98AD + E271A 2 V68A + S106T + A108T 1 S9R + P14S + R19F + A98AD 2 A151V + R170C 2 S99DA + P129PSN + P131A 2 P14D + A98AS + H120D + G195F + 1 S99AD + V244M + Q245K + N248D + K251R + 2 S212N + M222S T255A + S256N S49N + V203L + N218D 2 S9R + P14V + R19G + A98AD 2 V68A + S106M + N184D 2 S99AD + N248P + T255A + S256G 2 P55S + V68L + A158E + G160A 2 *0AQSVPWG + A98AD 2 V68A + A158C 2 T22A + S99AD 2 V68A + A158L + Y214C 2 K94N + A98T + S99L 2 A88V + S99AD + P131F 2 N76D + A174AL + A194P + A230V 1 P14T + A16P + I72V + S99SD + 2 P40L + N218D + A232S + Q236L + Q245E + 2 V244I + T260A S259N S99AD + P131F 2 A232L + Q236D + Q245E 1 R10H + N62D 2 A232T + Q236L + Q245D 2 V28I + A98AD + T224S 2 R170H + Q236A + Q245R 2 S9K + T22K + S99AD 2 A232L + Q236T + Q245D 2 P14S + S99AD + P131W 2 G97GG + P131H + Q137E + V268L 2 V68A + I72V + P131F 2 A88V + G97GV + P131H 2 S9R + S99AD 1 G97GA + H120Q + S130P + G264E 2 S9K + S99AD 2 G97GG + V139L 2 V28I + A88V + G100S + P131M 2 G97GG + Q137D 1 S103L + V104S + S106G 2 G97GG + H120D + Q137H 2 V68A + T224A 2 N185R 2 V68A + P131F 2 P131H + Q137E 1 A48T + V68A + P131M 1 V104I + H120N + P131H + Q137E 2 V68A + I72V + P131F 2 H120Q + Q137E 1 G100GE + P131F 2 S9R + A15T + G97GV + H120D 1 S99AD + P131F + T260A 1 G100S + H120Q + Q137H 2 R19G + A98AS 2 V68A + H120K + Q137E 2 G61R + N62D 1 G97GA + H120E 2 V68A + S106M + N184D 2 H120D + S128I + Q137D 2 P55S + V68L + A158E + G160A 2 G97GG + P131H 2 V68A + A158C 2 G97GG + H120N + L126I 2 R19W + G61S + S99SD + N204T + 2 S9R + A15T + G97GA + H120D + P131H + 2 Y263H + S265R Q137E A232T + Q236C 2 S9R + A15T + G97GV + P131T + Q137H 1 N62D + A232T + Q236C 2 S9R + A15T + G20* + L21F + N62D + Q245N 2 A232P + Q236L + Q245E 2 S9L + A15T + T22TV + V139L + Q245F 2 A232S + Q236L + Q245T + K251E 2 S132G + Q245F 1 S163C + Q236M + Q245T + S256G 2 S9R + A15T + T22TG + N62D + V139L + Q245V 1 N218D + A232L + Q236F + Q245F 2 S9L + A15T + T22TV + V139L + Q245F + L262S 2 S163N + A232L + Q236S + Q245E 2 S9R + A15T + T22TL + N62D + Q245W 2 A232S + Q236S + Q245E 2 V68A + A158L + Y214C 2 V68A + V203L 2 N62D + V150I 2 V68S + A158D 2 S3T + P14Q + A15M + R19K + N62D + S144D 2 I8V + A15T + R19K + A85T + S99SD + 2 P14Q + R19W + V51I + G61E + S99SD + 2 A114V + V244I + S256N + Y263H2 V139I + T260R L111F + Y263H 2 S3T + P14L + H17R + S99SD + V139I + S144D 2 P52V + S78T + S99SD 2 S3A + V30I + S99SD + S106G + N248S 2 A15M + S99SD + V268I 2 I8V + A15T + S99SD 2 S99G + S128N + N183D + A232L + 1 S3T + S9R + P14H + A15M + R19L + S99SD + 2 Q236T + Q245R 1 V139I S99R + S101SA 1 S9R + A15T + G97GG + H120D + Q137E 2 L96LA + A98T + P131AA 2 S9R + A15T + G20A + G97GV + H120D + P131H 2 A98E + S99P 2 S163N + A232L + Q236A + Q245G 2 V28I + S99AD + P131F 2 N173D + A232L + Q236A + Q245N 2 S9R + A15T + G97GV + Q137H 1 P55S + V68A + S106M + A108T + P129T 2 V81A + P131T + A133S + Q137E 1 K27R + V68L + G118D + A158E 1 N43D + V68A + S106F + N238D 2 A98E + S99A + S101SK 2 V68A + V203F 2 V68A + N140D + T143A + S144N 2 V68A + S106E 2 N62D + N140K + T143A + S144D 2 V68A + S106I 2 S9F + P14T + R19L + A98AD 2 V68A + A158M + R170C 1 S9V + P14R + R19F + A98AD 2 V68A + P129T + N218D 2 S99A + S99SD + G258K + L262Q 2 V68S + P129E 2 S87C + S99SA + S99D + P131A 2 V68S + P129D 2 S99A + S99SD + G258K + L262Q 2 V68L + P129E + N261D 2 V28I + S99A + *99aD + P131F 1 G97GV + H120D 2 A85T + G102D + S106T + K237R 2 P131A + A133ASA 2 V68A + T71A 2 L111F + Y263H 2 G61GS 2 V11A + G61GE + V227A + S240F 2 G100L 2 A133E + S144K + N218D 2 A133D 2 S128A + P129S + S130SP 2 V68A 2 G61GE 2 N123D 2 -
TABLE V Wash performance test results, Assay B. Mutations Score S9R + A15T + T22TW + N204D + Q245I 2 S9R + A15T + G97GG + P131S + Q137H 2 S9R + A15T + T22TG + N62D + V139L + Q245G 2 S9R + A15T + T22TL + N62D + I107V + V139L + Q245W 2 S9G + A15T + G97GA + Q137H 1 S9R + A15T + V68A + Q245R 2 S9R + A15T + G97GA + H120N + S212L 2 S9R + A15T + L96LG + H120D + P131H + R186L 2 S9R + A15T + G97GA + H120D + Q137D 2 S9R + A15T + A16P + G97GA + P131S + Q137D + N204S 2 S9R + A15T + L21LP + T22TV + M119I + N218D + Q245I 2 S9R + A15T + G97GV + H120D + Q137H 1 S9R + A15T + L96LG + H120N + P131H + Q137E 2 S9R + A15T + L96LG + H120D + P131S + Q137E 2 S9R + A15T + H120N + P131T + N218D 2 V4A + S9R + A15T + G97GV + H120D 1 S9R + A15T + L96LG + H120D + G160D 2 S9R + A15T + T22TG + N62D + V139L + Q245S 2 S9R + A15T + G61E + A85T + P239L + Q245C 2 S9R + A15T + P131H + S144P 2 S9R + A15T + G97GA + Q137E 2 S9R + A15T + G97GA + H120Q + P131H + Q137E 2 S9R + A15T + L21LW + G100S + V139L + Q245V 1 S9R + A15T + G97GA + Q137H + N218S 2 S9R + A15T + L96LG + H120N + P131S + Q137H 2 S9R + A15T + G97GA + H120N + Q137E 2 S9R + A15T + L96LG + P131T + Q137H 2 S9R + A15T + L96LG + H120N + P131S 2 S9R + A15T + V68A + Q137D 1 S9R + A15T + G97GA + H120Y + Q137H 2 S9R + A15T + G97GA + Q137D 2 S9R + A15T + K94N + H120N + P131H 1 S9R + A15T + L96LG + P131H + Q137D 2 S9R + A15T + F50S + H120D + P131H 2 S9R + A15T + G97GA + H120N + Q137D + N248D 2 S9R + A15T + L96LG + P131Q + Q137D 2 S9R + A15T + T22G + V139L + Q245L 2 V139L + Q245R 2 S9R + A15T + Q245F 2 S9R + A15T + Q245S 2 S9R + A15T + G97GV + H120Q 1 S9R + A15T + G97GA + Q137E + L262V 1 S9R + A15T + G127E + P131R + Q137H 2 S9R + A13V + A15T + I35V + N62D + Q245F 2 S9R + A15T + Q245V 2 V139L + Q245F 2 S9R + A15T + T22A + V139L + Q245E 2 S9R + A15T + T22L + V139L + Q245V + A254S 2 S9R + R19L + A98AD 2 P14R + A98AD 2 S9R + A15T + Q245L 2 S9R + A15T + G61E + A85T + P239S + Q245V 2 S9R + A15T + G61E + A85T + Q206L + Q245R 2 P239T + Q245R 2 S9R + A15T + N62NG + Q245T 2 S9R + A15T + G61GP + Q245L 2 S9R + A15T + G61E + A85T + Q137H + Y209C + Q245G 2 S9R + A15T + G61E + A85T + P239S + Q245C 2 V68I + A98AD 2 V68A + N269K 1 N62D + Q245A + N252G + S265G 2 N218D + Q245G + N252H 2 S9R + A15T + G102S + M175T + Q245R + N252D 2 S9R + A15T + N62D + Q245W + N252V 2 S9R + A15T + N62D + Q245R + N252M 2 S9R + A15T + N62D + Q245W + N252S 2 S99SD + N204S + Q245R 1 N62D + Q245R 2 N62D + A151G 1 V68A + S106T 2 S99A + S99SD + V203L 2 A98AD + A215T 2 N62D + Q245G + N252T 2 A152P + Q245R + N252T 2 S163N + T213A + Q245R 2 S106L + Q245R + N252E 2 Q245W + N252Y 2 Q245W + N252V 2 R45H + Y171C + Q245W + N252S 2 G20R + A48T + R170C + Q245W + N252Q 2 N62D + N252T 2 N218D + Q245W + N252E 2 G20R + R170C + Q245R + N252V 2 S9R + P14I + R19K + A98AD + T274S 2 A98AE + V203I 2 V51A + V68A + S163G + V203A 2 N62D + Q245W + N252H 2 N62D + Q245W + N252A 2 G20R + N62D + V244I + Q245W + N252E 2 N204D + Q245S 2 N62D + Q245W + N252E 2 N62D + Q245R + N252V 2 S9R + A15T + S24P + G61E + A85T + P239S + Q245A 2 G102S + M222S + Q245L + N252D 2 A15M + V30I + N62D + S99N + L111I + V244A + S265N 2 V68A + S106A + G118D + Q245R + T255S + L257G + T274L 2 S3T + Q12D + R19W + V30I + S106G + I107M 2 V68A + A88T + V139L 2 V51I + L111I + G118D + Q245R 2 V68A + V203L 1 A1T + V68A + N116D + G118D 1 V68A + G118D + Q245R 2 N62D + V139I + N183D + N185S + V203I + Q245R + L262S 2 N62D + I72V 1 N62D + V81A + Q245R 1 T22A + V68A + S106T + G118D 1 V68A + L111I + V203I 1 G61E + V68A + A169G 1 V68A + L111V 1 V68A + G118D + V203A + K251R 1 V68A + G118D 1 A1V + V51A + V68A + V203I 2 V68A + V139L + A223G 1 N62D + Y214H + K237R 1 V68A + S106A + G118D + Q245R 2 S9R + A15T + T22A + N62D 2 A98Q + S99D 1 S9R + P14I + R19K + A98AD 2 S9R + A15M + A16P + T22S + S99AD 1 S99AD + T255R + S256N 2 S9R + A15T + T22TQ + S101P 1 S9R + A15T + H120R + Q137D + N173S 2 G97E 1 Q245W 2 S9R + A15T + L96LG + Q137E + Y209H 2 S9R + A15T + L111V + Q137E + G211D 1 S9R + A15T + L111I + Q137E 2 S9R + A15T + L111I + H120N + Q137E 2 S9R + A15T + L96LG + H120Q + Q137E 1 S9R + A15T + T260M 2 S9R + A15T 2 Q245I 2 S9R + A15T + H120G + Q137E + N218D 2 S9R + A15T + S130P 2 Q245F 2 S9R + A15T + N218D 2 G63E + N76D + A194P + A230V 2 S9R + A15T + T224A 2 G100S 2 S9R + A15T + D60DG 1 A138V + V139I + A194P + N218D + A230V 2 A108V + A169G + R170A + Y171H 1 I8V + P14L + R19L + V30I + I35V + 2 S57P + P129S + Q137D + S144D + S256N A133D + T134S + Q137A 1 Q137D 2 A98AH 1 V51D 2 Q12E + P14L + A15T 2 G63E + N76D + A194P + A230V 2 Q12E + P14L + A15T 2 G97GS 1 M222S + Q245G + N252G 1 V68I + V203L 2 V51A + S163T 2 S106A + A138G 2 V139I + A151G 2 S9R + A15T + S99C + H120N + P131S + Q137H + M222S 2 S9R + A15T + S99G + G100S + H120N + P131S + Q137H 2 A15T + N185D + M222S + Q245R + N252V 2 S9R + A15T + T22TL + G61E + L96LG + Q137D + Q245R 2 S9R + T22TL + G61E + G97GG + M119I + P131T 2 Y209H + M222S + Q245G + N252L 2 M222S + Q245M + N252E 2 S9R + A15T + N62D + H120N + P131T 2 S9R + A15T + V68A + N218D + Q245R 2 S9R + A15T + V68A + H120N + N218D + Q245R 1 S9R + A15T + V68A + A174V + Q245R 2 S9R + A15T + G46D + V68A + N218D + Q245R 2 G97D + A98N + S128G + S130T + P131D + T134A 2 S9R + A15T + V68A + A98M + Q245R + N248D 2 S9R + A15T + V68A + A98L + S99G + Q245R 2 S9R + A15T + A98G + S99C + H120N + P131S + Q137H 2 S9R + A15T + T38S + A98R + S99C + 2 G100S + H120N + P131S + Q137H A98V + S99C + Q245R 1 S9R + A15T + A98S + G100S + H120N + P131S + Q137H 1 S9R + A15T + G20* + L21F + N62D + Q245R 2 S9R + A15T + G20* + L21F + N62D + Q245R + S259G 2 A98S + G100S + Q245R 2 A98L + S99C + Q245R 2 S9R + A15T + G20* + L21F + N62E + Q245R 2 S9R + A15T + G20* + L21F + P52T + N62D + Q245R 2 S9R + A15T + V68A + S99G + Q245R + N261D 2 N62D + P131F + A172V 2 N62D + P131F 2 S99SD + Q245R 2 S9R + A13T + S99A + S99SD + P131F 2 S9R + A15T + N62S + H120N + P131T + N218D 2 A98R + G100C + Q245R 2 A98G + S99C + Q245R 2 A98T + S99G + G100S + S240F + Q245R 2 S9R + A15T + H120N + P131T + N218D + N269T 2 S9R + A15T + G61E + H120S + Q137D + V139L + N218D 2 S9R + A15T + L96LG + H120N + P131S + Q137H + M222S 1 S9R + A15T + G61E + A98S + S99M + Q245R 2 A98G + G100S + Q245R + N261D 2 S9R + A15T + V68A + A98L + Q245R 1 S9R + A15T + V68A + A98G + S99V + Q245R 1 S9R + A15T + V68A + A98M + S99G + Q245R + T274A 2 S9R + A15T + G61E + V68A + A98S + S99G + Q245R 2 S9R + A15T + A88V + A98R + S99G + 1 G100C + H120N + P131S + Q137H S9R + A15T + A98C + G100S + H120N + P131S + Q137H 1 S9R + A15T + G20* + L21F + G61E + *61aP + Q245R 1 S9R + A15T + V68A + A98G + S99I + K237R + Q245R S9R + A15T + V68A + H120N + P131S + Q137H + Q245R 2 A98S + S99G + G100S + Q245R 2 S9R + A15T + V68A + H120D + P131S + Q137H + Q245R 2 A98T + S99G + G100S + Q245R 2 S9R + A15T + A98S + S99G + G100S + 2 H120N + P131S + Q137H V68A + S106A + Q245R + N252D 2 V68A + S106A + Q245W 2 V68A + S106A + N252M + Y263C 1 V68A + S106A + Q245W + N252K 0 V68A + S106A + A174V + Q245R + N252D 1 S9R + A15T + V68A + Q245R + N252S 2 S9R + A15T + V68A 2 S9R + A15T + G20* + L21F + *61aS + V68A + G160D + Q245R 2 S9R + A15T + Y167I + R170L 2 S9R + A15T + G20* + L21F + *63aG + Q245R + N272V 2 S9R + A15T + G20* + L21F + *61aA + V68A + Q245R 2 S9R + A15T + V68A + A194T + Q245R + N252E 2 S9R + A15T + G20* + L21F + *62aS + N218D + Q245R 2 V68A + S106A + T213A 2 S9R + A15T + V28I + V68A + Q245R + N252A 2 V68A + S105G + S106A 2 S9R + A15T + V68A + H120N + P131S + Q137H + Q245M 2 -
Assay C Commercial detergent base European powder type 2 Detergent dosage 4 g/l Test solution volume 160 micro l pH as it is in detergent (app. 10-10.5) Wash time 20 min. Temperature 30° C. Water hardness 6-9° dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material EMPA 116 - The European powder type detergent was composed according to the provisions in Detergent Example 2. Water hardness was adjusted to 15° dH by addition of CaCl2*2H2O; MgCl2*6H2O; NaHCO3 (Ca2+:Mg2+:HCO3−=4:1:10) to the test system. After washing the textile pieces were flushed in tap water and air-dried.
-
TABLE VI Wash performance test results, Assay C. Mutations Score Q12E + P14L + A15T 2 P14R + A98AD 2 G100S 2 A169G + R170H 1 A98AD + A169G 1 A138V + V139I + A194P + N218D + A230V 2 S99A + S99SD + V203L 1 V68A + S106T 1 A98AD + A215T 2 A108V + A169G + R170A + Y171H 1 S3L + N62D + S163A + S190A 2 S9R + P14I + R19K + A98AD + T274S 2 S9R + A15T + G61E + A85T + N218D + P239S + Q245L 2 S9R + A15T + S24P + G61E + A85T + P239S + Q245A 2 S99SD + P131F 1 N62D + P131F + A172V 1 N62D + P131F 1 V68A + A88T + V139L 2 V68A + G118D + V203A 2 P40L + V68A + A108T + A138V + V203I 2 I8T + A98AD + T274R 2 A98AE + V203I 2 V51A + V68A + S163G + V203A 2 A1V + V51A + V68A + V203I 2 V68A + G100S 1 V68A + V203L 1 A1T + V68A + N116D + G118D 1 N62D + A169G + V203I + Q245R 1 G23S + S99SD + A194P + S242T + Q245R + T274R 1 S99SD + N204S + Q245R 2 N62D + Q245R 2 V68A + S106A + G118D + Q245R 2 V51I + L111I + G118D + Q245R 2 N62D + V139I + N183D + N185S + V203I + Q245R + L262S 2 N62D + I72V 1 S9R + R19L + A98AD 2 S9G + P14R + R19I + A98AD 1 S9R + A15T + T22L + V139L + Q245V + A254S 2 S9R + A15T + T224A 2 S9R + A15T + Q245L 2 S9R + A15T + N62NG + Q245T 1 S9R + A15T + N62ND + V139L + Q245E 1 S9R + A15T + N62ND + V139L + N261D 2 Y167I + R170L + Q245E 1 Y167I + R170L + Q245R 2 Y167I + R170L + Q245M 1 Y167I + R170L 1 S99SE + Q245R 2 S9R + A15T + G61E + A85T + Q137H + Y209C + Q245G 2 S9R + A15T + G61E + A85T + P239S + Q245C 1 G102S + M222S + Q245L + N252D 1 N62D + Q245A + N252G + S265G 1 N62D + Q245G + N252T 1 S9R + A15T + N62D + Q245W + N252V 2 S9R + A15T + N62D + Q245R + N252M 2 S9R + A15T + N62D + Q245W + N252S 1 S163N + T213A + Q245R 2 S106L + Q245R + N252E 2 Q245W + N252Y 2 Q245W + N252V 1 G20R + A48T + R170C + Q245W + N252Q 2 N62D + N252T 2 N218D + Q245W + N252E 2 G20R + R170C + Q245R + N252V 2 N62D + Q245W + N252H 2 N62D + Q245W + N252A 2 G20R + N62D + V244I + Q245W + N252E 2 N204D + Q245S 1 N62D + Q245W + N252E 2 N62D + Q245R + N252V 2 A98L + S99C + Q245R 2 N62D + A98R + Q245R 2 S9R + A15T + V68A + S99G + Q245R + N261D 2 S9R + A15T + G20* + L21F + N62D + Q245R 2 S9R + A15T + G20* + L21F + N62E + Q245R 2 V68I + A98AD 2 -
Assay D Commercial detergent base European powder type 1Detergent dosage 6 g/l Test solution volume 160 micro l Ph as it is in detergent (app. 10-10.5) Wash time 20 min. Temperature 30° C. Water hardness 6-9° dH Enzyme concentration in test solution 5 nM, 10 nM and 30 nM Test material C-10 swatches from Center for Testmaterials, Vlaardingen, NL - The European powder type detergent was composed according to the provisions in Detergent Example 2 at page 24 herein. Water hardness was adjusted to 15° dH by addition of CaCl2*2H2O; MgCl2*6H2O; NaHCO3 (Ca2+:Mg2+:HCO3−=4:1:10) to the test system. After washing the textile pieces were flushed in tap water and air-dried.
-
TABLE VII Wash performance test results, Assay D. Mutations Score G97GS 1 S9V + P14R + R19F + A98AD 1 S9R + A15T + L111I + Q137E 1 S9R + A15T + G97GA + Q137E 2 S9R + A15T + L96LG + Q137E + Y209H 1 S9R + A15T + L96LG + H120N + P131S 2 S9R + A15T + G97GV + H120Q 2 S9R + A15T + L96LG + H120Q + Q137E 2 S9R + A15T + G97GV + P131S 2 S9R + A15T + K94N + H120N + P131H 1 S9R + A15T + N76S + L111V + P131H + Q137D 1 S9R + A15T + F50S + H120D + P131H 2 S9R + A15T + L96LG + S130* 2 S9R + A15T + L96LG + P131Q + Q137D 2 S9R + A15T + G97GA + H120D + Q137H + M222V 1 S9R + A15T + G97GA + H120N + Q137D + N248D 2 S9R + A15T + L21LW + G100S + V139L + Q245V 1 S9R + A15T + G20*+ L21F + N62D + Q245N 2 S9R + A15T + L21LC + V139L + R186H + Q245M 1 S132G + Q245F 1 S9R + A15T + T22TG + N62D + V139L + Q245G 2 S9R + A15T + T22TL + N62D + I107V + V139L + Q245W 2 S9R + A15T + T22TQ + S101P 2 S9R + A15T + T22TG + N62D + V139L + Q245V 1 S9R + A15T + T22TL + N62D + Q245W 2 S9R + A15T + T22TW + N204D + Q245I 2 S9R + A15T + T22TG + N62D + V139L + Q245S 2 S9R + A15T + L21LP + T22TY + V139L + G160D + Q245L 1 Q245W 2 S9R + A15T + S130P 2 S9R + A15T + G61E + A85T + P239L + Q245C 2 S9R + A15T + L21LP + T22TV + M119I + N218D + Q245I 2 S9R + A15T + V68A + Q245R 2 S9R + A15T + T22A + V139L + Q245E 2 V139L + Q245R 2 S9R + A15T + Q245F 2 S9R + A15T + Q245S 2 S9R + A15T + T260M 2 S9R + A15T 2 S9R + A15T + L21LG + T22TV + V139L + N204D + Q245N 1 V139L + Q245F 2 S9R + A15T + T22G + V139L + Q245L 2 S9R + A15T + Q245V 1 Q245F 2 S9R + Q245C 2 S9R + A15T + N218D 1 S9R + A13V + A15T + I35V + N62D + Q245F 2 S99G + S128N + N183D + A232L + Q236T + Q245R 2 S163N + A232L + Q236A + Q245G 2 S163C + Q236M + Q245T + S256G 1 N218D + A232L + Q236F + Q245F 1 S163N + A232L + Q236S + Q245E 2 G97GA + H120E 1 G97GG + P131H 2 S9R + A15T + G97GA + H120D + P131H + Q137E 1 S9R + A15T + G97GV + Q137H 2 S9R + A15T + G97GV + H120N 2 S9R + A15T + G97GG + P131S + Q137H 2 S9R + A15T + G97GG + H120N + Q137D 2 S9R + A15T + H120Q + P131C + Q137H 2 S9R + A15T + G97GV + H120D + Q137H 2 S9R + A15T + A16P + G97GA + P131S + Q137D + N204S 2 S9R + A15T + G97GG + H120D + P131H + Q137H 1 S9R + A15T + G97GV + H120E + Q137H 2 S9R + A15T + G97GV + P131T + Q137H 1 S9R + A15T + G97GV + H120Q + Y263F 2 S9R + A15T + G97GV + S106A + P131H 1 S9R + A15T + G97GG + L111I + P131T + Q137H 1 S9R + A15T + G97GV + P131H + Q137H 2 S9R + A15T + G20A + G97GV + H120D + P131H 1 S9R + A15T + G97GA + H120D + P131S + Q137E 1 S9G + A15T + G97GA + Q137H 1 S9R + A15T + H120R + Q137D + N173S 1 S9R + A15T + L96LG + H120N + P131H + Q137E 2 S9R + A15T + L96LG + H120D + P131S + Q137E 2 S9R + A15T + H120N + P131T + N218D 2 S9R + A15T + G97GA + H120D + Q137D 2 S9R + A15T + L96LG + H120D + P131H + R186L 2 S9R + A15T + G97GA + R186C 2 V4A + S9R + A15T + G97GV + H120D 1 S9R + A15T + L96LG + H120D + G160D 2 S9R + A15T + G97GA + H120N + S212L 2 S9R + A15T + G97GA + Q137H + N218S 2 S9R + A15T + H120D + Q137D 2 S9R + A15T + N77S + L96LG + H120D + P131Q 1 S9R + A15T + G97GA + H120N + Q137E 1 S9R + A15T + G97GA + Q137E + L262V 2 S9R + A15T + P131H + S144P 2 S9R + A15T + G127E + P131R + Q137H 2
Claims (20)
1-15. (canceled)
16. A variant of a parent subtilase comprising substitutions at positions 9 and 15, wherein the variant has protease activity and each position corresponds to a position of the amino acid sequence of SEQ ID NO: 1.
17. The variant of claim 16 , wherein the substitutions are S9R+A15T.
18. The variant of claim 16 , further comprising a substitution at position 68.
19. The variant of claim 18 , wherein the substitution at position 68 is V68A.
20. The variant of claim 17 , further comprising a substitution at position 68.
21. The variant of claim 20 , wherein the substitution at position 68 is V68A.
22. The variant of claim 16 , comprising a set of substitutions selected from the group consisting of:
23. The variant of claim 16 , wherein the parent subtilase belongs to the sub-group I-S1.
24. The variant of claim 16 , wherein the parent subtilase belongs to the sub-group I-S2.
25. The variant of claim 16 , wherein the parent subtilase is subtilisin 309.
26. The variant of claim 16 , further comprising one or more of the modifications K27R, *36D, S56P, N62D, V68A, N76D, S87N, G97N, S99SE, S101G, S103A, V104A, V104I, V104N, V104Y, S106A, H120D, H120N, N123S, G159D, Y167A, R170S, R170L, A194P, N204D, V205I, Q206E, L217D, N218S, N218D, M222S, M222A, T224S, A232V, K235L, Q236H, Q245R, N248D, N252K, T274A, S101G+V104N, S87N+S101G+V104N, K27R+V104Y+N123S+T274A, N76D+S103A+V104I, S99D+S101R+S103A+V1041+G160S, S3T+V4I+S99D+S100R+S103A+V104I+G160S+V199M+V205I+L217D, S3T+V4I+S99D+S100R+S103A+V104I+G160S+A194P+V199M+V205I+L217D, S3T+V4I+S99D+S100R+S103A+V104I+G160S+V2051 and N76D+V104A.
27. The variant of claim 16 , further comprising the following substitutions: S101G+S103A+V104I+G159D+A232V+Q236H+Q245R+N248D+N252K.
28. A cleaning or detergent composition, comprising a variant of claim 16 and a surfactant.
29. A composition of claim 28 , which additionally comprises one or more of an amylase, cellulase, cutinase, esterase, beta-galactosidase, glycoamylase, hemicellulase, lactase, ligninase, lipase, polygalacturonase, and protease.
30. An isolated DNA sequence encoding a protease variant of claim 16 .
31. An expression vector comprising the isolated DNA sequence of claim 30 .
32. A microbial host cell transformed with the expression vector of claim 31 .
33. A microbial host cell of claim 32 , which is a Bacillus.
34. A method for producing a protease variant, comprising
(a) culturing a host of claim 32 under conditions conducive to the expression and secretion of the variant, and
(b) recovering the protease variant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/403,859 US20090181875A1 (en) | 2002-11-06 | 2009-03-13 | Subtilase variants |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201705 | 2002-11-06 | ||
DKPA200201705 | 2002-11-06 | ||
US42715602P | 2002-11-18 | 2002-11-18 | |
DKPA200201933 | 2002-12-18 | ||
DKPA200201933 | 2002-12-18 | ||
US43472302P | 2002-12-19 | 2002-12-19 | |
US50753703P | 2003-10-01 | 2003-10-01 | |
US10/699,394 US7888093B2 (en) | 2002-11-06 | 2003-10-31 | Subtilase variants |
US12/403,859 US20090181875A1 (en) | 2002-11-06 | 2009-03-13 | Subtilase variants |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/699,394 Division US7888093B2 (en) | 2002-11-06 | 2003-10-31 | Subtilase variants |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090181875A1 true US20090181875A1 (en) | 2009-07-16 |
Family
ID=32738977
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/699,394 Expired - Lifetime US7888093B2 (en) | 2002-11-06 | 2003-10-31 | Subtilase variants |
US12/403,859 Abandoned US20090181875A1 (en) | 2002-11-06 | 2009-03-13 | Subtilase variants |
US12/973,220 Abandoned US20120149624A1 (en) | 2002-11-06 | 2010-12-20 | Subtilase Variants |
US12/974,519 Expired - Lifetime US9732310B2 (en) | 2002-11-06 | 2010-12-21 | Subtilase variants |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/699,394 Expired - Lifetime US7888093B2 (en) | 2002-11-06 | 2003-10-31 | Subtilase variants |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/973,220 Abandoned US20120149624A1 (en) | 2002-11-06 | 2010-12-20 | Subtilase Variants |
US12/974,519 Expired - Lifetime US9732310B2 (en) | 2002-11-06 | 2010-12-21 | Subtilase variants |
Country Status (1)
Country | Link |
---|---|
US (4) | US7888093B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090099056A1 (en) * | 1997-08-29 | 2009-04-16 | Novozymes A/S | Protease Variants and Compositions |
US20130123162A1 (en) * | 2011-11-10 | 2013-05-16 | The Procter & Gamble Company | Consumer products |
RU2639534C2 (en) * | 2009-09-25 | 2017-12-21 | Новозимс А/С | Application of protease versions |
RU2651525C2 (en) * | 2009-09-25 | 2018-04-19 | Новозимс А/С | Subtilase variants |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK6488D0 (en) * | 1988-01-07 | 1988-01-07 | Novo Industri As | ENZYMES |
EP2258852A1 (en) * | 2000-04-28 | 2010-12-08 | Novozymes A/S | Lipolytic enzyme variant |
US6893855B2 (en) * | 2000-10-13 | 2005-05-17 | Novozymes A/S | Subtilase variants |
DK200101090A (en) | 2001-07-12 | 2001-08-16 | Novozymes As | Subtilase variants |
US7888093B2 (en) * | 2002-11-06 | 2011-02-15 | Novozymes A/S | Subtilase variants |
US7824896B2 (en) * | 2004-04-02 | 2010-11-02 | Novozymes A/S | Subtilase variants having altered lmmunogenicity |
ATE529505T1 (en) * | 2005-07-08 | 2011-11-15 | Novozymes As | SUBTLE VARIANTS |
US20070161531A1 (en) * | 2005-07-08 | 2007-07-12 | Novozymes A/S | Subtilase variants |
JP2009534022A (en) * | 2006-04-20 | 2009-09-24 | ノボザイムス アクティーゼルスカブ | A sabinase variant with improved detergency against egg stains |
EP2100947A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
RU2010153866A (en) * | 2008-06-06 | 2012-07-20 | ДАНИСКО ЮЭс ИНК. (US) | COMPOSITIONS AND METHODS INCLUDING THE APPLICATION OF OPTIONAL MICROBIAL PROTEASES |
JP5727378B2 (en) * | 2008-11-11 | 2015-06-03 | ダニスコ・ユーエス・インク | Compositions and methods comprising serine protease variants |
ES2809509T3 (en) * | 2011-05-05 | 2021-03-04 | Procter & Gamble | Compositions and Methods Comprising Serine Protease Variants |
AU2012277721B2 (en) | 2011-06-30 | 2017-06-22 | Novozymes A/S | Alpha-amylase variants |
EP3569611A1 (en) | 2013-04-23 | 2019-11-20 | Novozymes A/S | Liquid automatic dish washing detergent compositions with stabilised subtilisin |
EP3013950B1 (en) * | 2013-06-27 | 2018-08-08 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
UA119333C2 (en) * | 2013-12-05 | 2019-06-10 | Філіп Морріс Продактс С.А. | HEATING PRODUCT GENERATED BY AEROSOL WITH HEAT DISTRIBUTION WRAP |
BR112017000102B1 (en) * | 2014-07-04 | 2023-11-07 | Novozymes A/S | SUBTYLASE VARIANTS OF A PROGENITOR SUBTYLASE, DETERGENT COMPOSITION, USE THEREOF AND METHOD FOR PRODUCING A SUBTYLASE VARIANT THAT HAS PROTEASE ACTIVITY |
WO2016066757A2 (en) * | 2014-10-30 | 2016-05-06 | Novozymes A/S | Protease variants and polynucleotides encoding same |
ES3017699T3 (en) * | 2014-12-15 | 2025-05-13 | Henkel Ag & Co Kgaa | Detergent composition comprising subtilase variants |
CN107002060A (en) * | 2014-12-19 | 2017-08-01 | 诺维信公司 | Ease variants and the polynucleotides encoded to it |
CN107002061A (en) | 2014-12-19 | 2017-08-01 | 诺维信公司 | Ease variants and the polynucleotides encoded to it |
WO2016202839A2 (en) * | 2015-06-18 | 2016-12-22 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2017037097A1 (en) * | 2015-09-01 | 2017-03-09 | Novozymes A/S | Laundry method |
CN108884452A (en) * | 2016-01-21 | 2018-11-23 | 诺维信公司 | Polypeptides having protease activity and polynucleotides encoding them |
EP3275988B1 (en) * | 2016-07-26 | 2020-07-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
CN113302296A (en) * | 2019-01-28 | 2021-08-24 | 诺维信公司 | Subtilase variants and compositions comprising the same |
Citations (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336611A (en) * | 1988-02-11 | 1994-08-09 | Gist-Brocades N.V. | PB92 serine protease muteins and their use in detergents |
US5340735A (en) * | 1991-05-29 | 1994-08-23 | Cognis, Inc. | Bacillus lentus alkaline protease variants with increased stability |
US5389307A (en) * | 1990-11-14 | 1995-02-14 | Novo Nordisk A/S | Detergent composition comprising an alkyl sulfate and a subtilisin variant |
US5482849A (en) * | 1990-12-21 | 1996-01-09 | Novo Nordisk A/S | Subtilisin mutants |
US5501820A (en) * | 1991-10-16 | 1996-03-26 | Lever Brothers Company, Division Of Conopco, Inc. | Aqueous enzymatic detergent compositions |
US5567601A (en) * | 1993-06-01 | 1996-10-22 | University Of Maryland | Subtilisin mutants lacking a primary calcium binding site |
US5665587A (en) * | 1989-06-26 | 1997-09-09 | Novo Nordisk A/S | Modified subtilisins and detergent compositions containing same |
US5700676A (en) * | 1984-05-29 | 1997-12-23 | Genencor International Inc. | Modified subtilisins having amino acid alterations |
US5741694A (en) * | 1988-01-07 | 1998-04-21 | Novo Nordisk A/S | Useful mutations of bacterial alkaline protease |
US5741644A (en) * | 1992-07-07 | 1998-04-21 | Hitachi, Ltd. | DNA sequencing by extension of probe chip immobilized oligonucleotides |
US5780285A (en) * | 1995-03-03 | 1998-07-14 | Genentech, Inc. | Subtilisin variants capable of cleaving substrates containing dibasic residues |
US5837517A (en) * | 1995-05-05 | 1998-11-17 | Novo Nordisk A/S | Protease variants and compositions |
US5837516A (en) * | 1995-03-03 | 1998-11-17 | Genentech, Inc. | Subtilisin variants capable of cleaving substrates containing basic residues |
US6121226A (en) * | 1996-05-03 | 2000-09-19 | The Procter & Gamble Company | Compositions comprising cotton soil release polymers and protease enzymes |
US6245901B1 (en) * | 1997-02-06 | 2001-06-12 | Novo Nordisk A/S | Modified polypeptide |
US6287841B1 (en) * | 1988-02-11 | 2001-09-11 | Genencor International, Inc. | High alkaline serine protease |
US6300116B1 (en) * | 1996-11-04 | 2001-10-09 | Novozymes A/S | Modified protease having improved autoproteolytic stability |
US6312936B1 (en) * | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
US6376450B1 (en) * | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
US6436690B1 (en) * | 1993-09-15 | 2002-08-20 | The Procter & Gamble Company | BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted |
US6455295B1 (en) * | 1995-03-08 | 2002-09-24 | The Procter & Gamble Company | Subtilisin Carlsberg variants having decreased adsorption and increased hydrolysis |
US6475765B1 (en) * | 1995-03-09 | 2002-11-05 | Procter & Gamble Company | Subtilisin DY variants having decreased adsorption and increased hydrolysis |
US6555355B1 (en) * | 1997-08-29 | 2003-04-29 | Novozymes, A/S | Protease variants and compositions |
US6566115B1 (en) * | 1999-07-22 | 2003-05-20 | The Procter & Gamble Company | Protease conjugates having sterically protected clip sites |
US6599730B1 (en) * | 1994-05-02 | 2003-07-29 | Procter & Gamble Company | Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
US20030157645A1 (en) * | 2001-12-21 | 2003-08-21 | Direvo Bio Tech Ag. | Subtilisin variants with improved characteristics |
US6727085B2 (en) * | 1999-12-15 | 2004-04-27 | Fanoe Tina Sejersgaard | Subtilase variants having an improved wash performance on egg stains |
US6831053B1 (en) * | 1998-10-23 | 2004-12-14 | The Procter & Gamble Company | Bleaching compositions comprising multiply-substituted protease variants |
US6902922B2 (en) * | 2000-04-03 | 2005-06-07 | Novozymes A/S | Subtilisin variants |
US20050181446A1 (en) * | 2000-04-28 | 2005-08-18 | Novozymes A/S | Protein variants having modified immunogenicity |
US7306937B2 (en) * | 2002-01-16 | 2007-12-11 | Genencor International, Inc. | Multiply-substituted protease variants |
US7332320B2 (en) * | 2001-12-31 | 2008-02-19 | Genencor International, Inc. | Protease producing an altered immunogenic response and methods of making and using the same |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ208612A (en) * | 1983-06-24 | 1991-09-25 | Genentech Inc | Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations |
WO1990014420A1 (en) * | 1989-05-17 | 1990-11-29 | Amgen Inc. | Multiply mutated subtilisins |
DK316989D0 (en) | 1989-06-26 | 1989-06-26 | Novo Nordisk As | ENZYMES |
JPH04500384A (en) | 1989-06-26 | 1992-01-23 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Enzyme detergent composition |
US6271012B1 (en) | 1989-10-11 | 2001-08-07 | Genencor International, Inc. | Protease muteins and their use in detergents |
DE69212390T2 (en) | 1991-05-01 | 1997-01-09 | Unilever Nv | Detergent compositions containing stabilized enzymes |
US5275945A (en) * | 1991-10-08 | 1994-01-04 | Vista Chemical Company | Alkaline proteases stable in heavy-duty detergent liquids |
GB9220669D0 (en) | 1992-09-30 | 1992-11-11 | Unilever Plc | Detergent composition |
CN1113953A (en) | 1994-06-01 | 1995-12-27 | 中国科学院生物物理研究所 | No.118 Position mutation of bacillus subtilis alkaline protease and its thermal stable enzyme |
IL117350A0 (en) | 1995-03-09 | 1996-07-23 | Procter & Gamble | Proteinase k variants having decreased adsorption and increased hydrolysis |
EP0827531A2 (en) | 1995-05-05 | 1998-03-11 | Unilever N.V. | Subtilisin variants |
WO1996034946A1 (en) | 1995-05-05 | 1996-11-07 | Novo Nordisk A/S | Protease variants and compositions |
WO1998006279A1 (en) | 1996-08-09 | 1998-02-19 | Gibson Suzanne M | Heat-stable protein microparticles and no-shear process for producing same |
JP2001514846A (en) * | 1997-08-29 | 2001-09-18 | ノボ ノルディスク アクティーゼルスカブ | Protease variants and compositions |
EP0913458B1 (en) | 1997-10-22 | 2004-06-16 | The Procter & Gamble Company | Liquid hard-surface cleaning compositions |
US6773907B2 (en) * | 1997-11-21 | 2004-08-10 | Peter Kamp Hansen | Subtilase enzymes |
DE69830743T2 (en) | 1997-11-21 | 2006-04-27 | Novozymes A/S | PROTEASE VARIANTS AND COMPOSITIONS |
EP1082442A1 (en) | 1998-03-26 | 2001-03-14 | The Procter & Gamble Company | Serine protease variants having amino acid substitutions |
AU1223000A (en) | 1998-10-23 | 2000-05-15 | Procter & Gamble Company, The | Methods for screening protease variants for use in detergent compositions |
CA2355580C (en) | 1998-12-18 | 2011-03-15 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
CN1342199B (en) | 1998-12-18 | 2010-12-08 | 诺沃奇梅兹有限公司 | I-S1 and I-S2 subgroups subtilases with additional amino acid residues in the active site loop region |
CA2353789C (en) | 1998-12-21 | 2012-02-14 | Genencor International, Inc. | Chemically modified enzymes with multiple charged variants |
DE60040283D1 (en) | 1999-05-20 | 2008-10-30 | Novozymes As | SUBTILASE ENZYMES OF I-S1 AND I-S2 SUB-GROUPS WITH AT LEAST ONE ADDITIONAL AMINO ACID BETWEEN POSITION 97 AND 98 |
AU4393100A (en) | 1999-05-20 | 2000-12-12 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additionalamino acid residue between positions 125 and 126 |
KR20020021398A (en) * | 1999-07-22 | 2002-03-20 | 데이비드 엠 모이어 | Subtilisin protease variants having amino acid substitutions in defined epitope regions |
CA2394971C (en) | 1999-12-15 | 2016-01-19 | Novozymes A/S | Subtilase variants having an improved wash performance on egg stains |
AU7961401A (en) | 2000-08-21 | 2002-03-04 | Novozymes As | Subtilase enzymes |
US6541234B1 (en) | 2000-09-11 | 2003-04-01 | University Of Maryland Biotechnology Institute | Calcium free subtilisin mutants |
EP2360247A1 (en) | 2000-10-13 | 2011-08-24 | Novozymes A/S | Subtilase variants |
DK200101090A (en) | 2001-07-12 | 2001-08-16 | Novozymes As | Subtilase variants |
EP2287321B1 (en) | 2002-01-16 | 2014-08-13 | Danisco US Inc. | Multiply-substituted protease variants |
JP2005531307A (en) * | 2002-06-26 | 2005-10-20 | ノボザイムス アクティーゼルスカブ | Subtilases and subtilase variants with altered immunogenicity |
TWI319007B (en) | 2002-11-06 | 2010-01-01 | Novozymes As | Subtilase variants |
US7888093B2 (en) * | 2002-11-06 | 2011-02-15 | Novozymes A/S | Subtilase variants |
EP1651751B1 (en) | 2003-08-06 | 2015-11-18 | University Of Maryland Biotechnology Institute | Engineered proteases for affinity purification and processing of fusion proteins |
ATE529505T1 (en) | 2005-07-08 | 2011-11-15 | Novozymes As | SUBTLE VARIANTS |
US20070161531A1 (en) * | 2005-07-08 | 2007-07-12 | Novozymes A/S | Subtilase variants |
JP5497440B2 (en) | 2006-10-06 | 2014-05-21 | ノボザイムス アクティーゼルスカブ | Detergent composition and combined use of enzymes in the composition |
EP2480663B1 (en) * | 2009-09-25 | 2017-11-15 | Novozymes A/S | Use of variants of the serin protease subtilisin |
BR112012006487A8 (en) * | 2009-09-25 | 2018-04-24 | Novozymes As | precursor subtilisin variant, isolated polynucleotide, nucleic acid construct, expression vector, host cell, cleaning composition or detergent, and method for producing a variant |
-
2003
- 2003-10-31 US US10/699,394 patent/US7888093B2/en not_active Expired - Lifetime
-
2009
- 2009-03-13 US US12/403,859 patent/US20090181875A1/en not_active Abandoned
-
2010
- 2010-12-20 US US12/973,220 patent/US20120149624A1/en not_active Abandoned
- 2010-12-21 US US12/974,519 patent/US9732310B2/en not_active Expired - Lifetime
Patent Citations (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5700676A (en) * | 1984-05-29 | 1997-12-23 | Genencor International Inc. | Modified subtilisins having amino acid alterations |
US5741694A (en) * | 1988-01-07 | 1998-04-21 | Novo Nordisk A/S | Useful mutations of bacterial alkaline protease |
US6287841B1 (en) * | 1988-02-11 | 2001-09-11 | Genencor International, Inc. | High alkaline serine protease |
US5336611A (en) * | 1988-02-11 | 1994-08-09 | Gist-Brocades N.V. | PB92 serine protease muteins and their use in detergents |
US5665587A (en) * | 1989-06-26 | 1997-09-09 | Novo Nordisk A/S | Modified subtilisins and detergent compositions containing same |
US5389307A (en) * | 1990-11-14 | 1995-02-14 | Novo Nordisk A/S | Detergent composition comprising an alkyl sulfate and a subtilisin variant |
US5482849A (en) * | 1990-12-21 | 1996-01-09 | Novo Nordisk A/S | Subtilisin mutants |
US5340735A (en) * | 1991-05-29 | 1994-08-23 | Cognis, Inc. | Bacillus lentus alkaline protease variants with increased stability |
US5500364A (en) * | 1991-05-29 | 1996-03-19 | Cognis, Inc. | Bacillus lentus alkaline protease varints with enhanced stability |
US5501820A (en) * | 1991-10-16 | 1996-03-26 | Lever Brothers Company, Division Of Conopco, Inc. | Aqueous enzymatic detergent compositions |
US5741644A (en) * | 1992-07-07 | 1998-04-21 | Hitachi, Ltd. | DNA sequencing by extension of probe chip immobilized oligonucleotides |
US5567601A (en) * | 1993-06-01 | 1996-10-22 | University Of Maryland | Subtilisin mutants lacking a primary calcium binding site |
US6436690B1 (en) * | 1993-09-15 | 2002-08-20 | The Procter & Gamble Company | BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted |
US6599730B1 (en) * | 1994-05-02 | 2003-07-29 | Procter & Gamble Company | Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
US5780285A (en) * | 1995-03-03 | 1998-07-14 | Genentech, Inc. | Subtilisin variants capable of cleaving substrates containing dibasic residues |
US5837516A (en) * | 1995-03-03 | 1998-11-17 | Genentech, Inc. | Subtilisin variants capable of cleaving substrates containing basic residues |
US6455295B1 (en) * | 1995-03-08 | 2002-09-24 | The Procter & Gamble Company | Subtilisin Carlsberg variants having decreased adsorption and increased hydrolysis |
US6475765B1 (en) * | 1995-03-09 | 2002-11-05 | Procter & Gamble Company | Subtilisin DY variants having decreased adsorption and increased hydrolysis |
US5837517A (en) * | 1995-05-05 | 1998-11-17 | Novo Nordisk A/S | Protease variants and compositions |
US6121226A (en) * | 1996-05-03 | 2000-09-19 | The Procter & Gamble Company | Compositions comprising cotton soil release polymers and protease enzymes |
US6300116B1 (en) * | 1996-11-04 | 2001-10-09 | Novozymes A/S | Modified protease having improved autoproteolytic stability |
US6245901B1 (en) * | 1997-02-06 | 2001-06-12 | Novo Nordisk A/S | Modified polypeptide |
US6555355B1 (en) * | 1997-08-29 | 2003-04-29 | Novozymes, A/S | Protease variants and compositions |
US6312936B1 (en) * | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
US6482628B1 (en) * | 1997-10-23 | 2002-11-19 | Genencor International, Inc. | Multiply-substituted protease variants |
US6927055B2 (en) * | 1997-10-23 | 2005-08-09 | Genencor International, Inc. | Multiply-substituted protease variants |
US6673590B1 (en) * | 1997-10-23 | 2004-01-06 | Genencor International, Inc. | Multiply-substituted protease variants with altered net charge for use in detergents |
US6815193B2 (en) * | 1997-10-23 | 2004-11-09 | Genencor International, Inc. | Multiply-substituted protease variants |
US6376450B1 (en) * | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
US6831053B1 (en) * | 1998-10-23 | 2004-12-14 | The Procter & Gamble Company | Bleaching compositions comprising multiply-substituted protease variants |
US6566115B1 (en) * | 1999-07-22 | 2003-05-20 | The Procter & Gamble Company | Protease conjugates having sterically protected clip sites |
US6727085B2 (en) * | 1999-12-15 | 2004-04-27 | Fanoe Tina Sejersgaard | Subtilase variants having an improved wash performance on egg stains |
US6902922B2 (en) * | 2000-04-03 | 2005-06-07 | Novozymes A/S | Subtilisin variants |
US6838425B2 (en) * | 2000-04-20 | 2005-01-04 | The Procter & Gamble Company | Cleaning compositions containing multiply-substituted protease variants |
US6610642B2 (en) * | 2000-04-20 | 2003-08-26 | The Procter And Gamble Company | Cleaning compositions containing multiply-substituted protease variants |
US20050181446A1 (en) * | 2000-04-28 | 2005-08-18 | Novozymes A/S | Protein variants having modified immunogenicity |
US20030157645A1 (en) * | 2001-12-21 | 2003-08-21 | Direvo Bio Tech Ag. | Subtilisin variants with improved characteristics |
US7332320B2 (en) * | 2001-12-31 | 2008-02-19 | Genencor International, Inc. | Protease producing an altered immunogenic response and methods of making and using the same |
US7306937B2 (en) * | 2002-01-16 | 2007-12-11 | Genencor International, Inc. | Multiply-substituted protease variants |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090099056A1 (en) * | 1997-08-29 | 2009-04-16 | Novozymes A/S | Protease Variants and Compositions |
US20110028378A1 (en) * | 1997-08-29 | 2011-02-03 | Novozymes A/S | Protease Variants and Compositions |
RU2639534C2 (en) * | 2009-09-25 | 2017-12-21 | Новозимс А/С | Application of protease versions |
RU2651525C2 (en) * | 2009-09-25 | 2018-04-19 | Новозимс А/С | Subtilase variants |
US20130123162A1 (en) * | 2011-11-10 | 2013-05-16 | The Procter & Gamble Company | Consumer products |
Also Published As
Publication number | Publication date |
---|---|
US9732310B2 (en) | 2017-08-15 |
US20110092408A1 (en) | 2011-04-21 |
US7888093B2 (en) | 2011-02-15 |
US20120149624A1 (en) | 2012-06-14 |
US20040147008A1 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9732310B2 (en) | Subtilase variants | |
EP2138574B1 (en) | Subtilase variants | |
EP1904628B1 (en) | Subtilase variants | |
US9133423B2 (en) | Subtilase variants | |
EP1183339A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 129 and 130 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |